| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule binding | KIF6 FMR1 CENPE TUBGCP2 REEP2 KIF20B CEP350 HAUS8 CCDC88A MACF1 KIF5A UXT GOLGA2 DNM2 NIN | 1.36e-07 | 308 | 180 | 15 | GO:0008017 |
| GeneOntologyMolecularFunction | tubulin binding | KIF6 FMR1 GIT1 CENPE TUBGCP2 REEP2 KIF20B CEP350 HAUS8 CCDC88A MACF1 KIF5A UXT GOLGA2 DNM2 NIN | 1.77e-06 | 428 | 180 | 16 | GO:0015631 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1D KIF6 FMR1 GIT1 CENPE MYO7A TUBGCP2 REEP2 KIF20B ADCY8 CEP350 HAUS8 CCDC88A KCNQ2 MACF1 ROCK1 KIF5A UXT MYO18B UTRN FMNL1 GOLGA2 DNM2 NIN | 5.34e-05 | 1099 | 180 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.49e-04 | 12 | 180 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.69e-04 | 35 | 180 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 3.00e-04 | 36 | 180 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 3.03e-04 | 15 | 180 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | small GTPase binding | 6.89e-04 | 321 | 180 | 10 | GO:0031267 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.06e-04 | 118 | 180 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 7.34e-04 | 20 | 180 | 3 | GO:0061665 | |
| GeneOntologyBiologicalProcess | neuron development | NPHP1 ADCY10 RIPOR2 AHI1 FMR1 GIT1 MYO7A LAMA1 KIF20B SYNGAP1 LRIG2 CCDC88A RND1 FEZ2 AP5Z1 TET1 PLXNA4 KCNQ2 MACF1 ROCK1 TRPM1 KIF5A MAPK9 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 RASAL1 MOV10 DNM2 NIN | 8.44e-07 | 1463 | 177 | 32 | GO:0048666 |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 CCP110 KIF6 RIPOR2 FMR1 GIT1 CENPE CUL9 CHD3 TUBGCP2 KIF20B SPICE1 CEP350 HAUS8 CFAP54 CCDC88A MACF1 ROCK1 KIF5A UXT CFAP61 AP3D1 GOLGA2 CCDC63 DNM2 NIN | 1.27e-06 | 1058 | 177 | 26 | GO:0007017 |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 EXOC6 RANBP2 MYO7A PHB2 FAM91A1 IPO4 SAR1A YWHAE REEP2 KIF20B SNX13 IPO9 PIK3C3 RGPD3 EXOC6B KCNQ2 OS9 KIF5A NUP188 AP3D1 | 1.61e-06 | 740 | 177 | 21 | GO:0006886 |
| GeneOntologyBiologicalProcess | neuron projection development | ADCY10 RIPOR2 AHI1 FMR1 GIT1 MYO7A LAMA1 KIF20B SYNGAP1 LRIG2 CCDC88A FEZ2 AP5Z1 TET1 PLXNA4 MACF1 ROCK1 KIF5A MAPK9 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 RASAL1 MOV10 DNM2 NIN | 4.88e-06 | 1285 | 177 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | SOX6 ADCY10 RIPOR2 AHI1 FMR1 FXR2 INPP5D RNF112 LAMA1 AR PPARGC1B CD34 PLXNA4 ADAMTS20 MACF1 SMARCD3 PRKDC MAPK9 IL4 AP3D1 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 NIN | 5.04e-06 | 1141 | 177 | 26 | GO:0045597 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | ADCY10 FMR1 FXR2 INPP5D RNF112 PPARGC1B PLXNA4 MACF1 SMARCD3 PRKDC IL4 AP3D1 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 NIN | 6.01e-06 | 614 | 177 | 18 | GO:0010720 |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 6.37e-06 | 114 | 177 | 8 | GO:0050772 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 EXOC6 RANBP2 FMR1 MYO7A PHB2 FAM91A1 IPO4 SAR1A YWHAE REEP2 KIF20B SNX13 EPG5 CCDC88A IPO9 MDN1 PIK3C3 AP5Z1 RGPD3 EXOC6B ABCD4 KCNQ2 OS9 KIF5A NUP188 UXT GRAMD1C AP3D1 GOLGA2 | 1.10e-05 | 1496 | 177 | 30 | GO:0046907 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | ADCY10 FMR1 FXR2 RNF112 PLXNA4 MACF1 SMARCD3 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 NIN | 1.23e-05 | 354 | 177 | 13 | GO:0050769 |
| GeneOntologyBiologicalProcess | organelle assembly | CCP110 RIPOR2 AHI1 FMR1 CENPE MYO7A TUBGCP2 AR SPICE1 CEP350 HAUS8 CFAP54 CCDC88A MDN1 FEZ2 PIK3C3 AP5Z1 CD34 PRKDC CFAP61 MAPK9 AP3D1 GOLGA2 CCDC63 DNM2 | 1.46e-05 | 1138 | 177 | 25 | GO:0070925 |
| GeneOntologyBiologicalProcess | cell cycle process | EXOC6 CCP110 RIPOR2 GIT1 CENPE RNF112 RNF212 PHB2 CUL9 CHD3 MCMDC2 TUBGCP2 KIF20B SPICE1 PPP1R7 HAUS8 PIK3C3 HASPIN MARF1 EXOC6B SMARCD3 ROCK1 PRKDC UXT EXOC7 CDC25C GOLGA2 DNM2 NIN | 1.48e-05 | 1441 | 177 | 29 | GO:0022402 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | ADCY10 FMR1 FXR2 RNF112 ADGRL1 PLXNA4 MACF1 SMARCD3 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 NIN | 1.59e-05 | 418 | 177 | 14 | GO:0051962 |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 CCDC14 ADCY10 RANBP2 AHI1 GIT1 PHB2 HUWE1 IPO4 YWHAE KIF20B CEP350 CCDC88A IPO9 PMPCA PIK3C3 RGPD3 HASPIN KCNQ2 MACF1 OS9 NUP188 AP3D1 GOLGB1 | 2.15e-05 | 1091 | 177 | 24 | GO:0033365 |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | EXOC6 AHI1 MYO7A FAM91A1 SAR1A EXOC6B KIF5A EXOC7 AP3D1 DNM2 | 2.47e-05 | 224 | 177 | 10 | GO:0051650 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | ADCY10 CCP110 RIPOR2 AHI1 FMR1 CCDC88A PLXNA4 MACF1 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 DNM2 NIN | 2.48e-05 | 494 | 177 | 15 | GO:0031346 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SOX6 ADCY10 RIPOR2 MYO7A LAMA1 AR KIF20B SYNGAP1 FEZ2 TET1 PLXNA4 MACF1 ROCK1 KIF5A PRKDC FMNL1 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 RASAL1 MOV10 DNM2 NIN | 3.24e-05 | 1194 | 177 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | vesicle targeting | 3.31e-05 | 71 | 177 | 6 | GO:0006903 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 4.34e-05 | 192 | 177 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | vesicle tethering involved in exocytosis | 5.02e-05 | 9 | 177 | 3 | GO:0090522 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 5.02e-05 | 9 | 177 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | vesicle localization | EXOC6 AHI1 MYO7A FAM91A1 SAR1A EXOC6B KIF5A EXOC7 AP3D1 DNM2 | 5.66e-05 | 247 | 177 | 10 | GO:0051648 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ADCY10 LAMA1 KIF20B SYNGAP1 FEZ2 TET1 PLXNA4 MACF1 ROCK1 KIF5A PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 RASAL1 MOV10 DNM2 NIN | 6.28e-05 | 802 | 177 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of cell development | ADCY10 SETD1A FMR1 FXR2 TCP11 INPP5D RNF112 SYNGAP1 PPARGC1B PLXNA4 TJP2 MACF1 SMARCD3 ROCK1 PRKDC IL4 AP3D1 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 NIN | 6.59e-05 | 1095 | 177 | 23 | GO:0060284 |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 7.13e-05 | 10 | 177 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | pronephric nephron tubule development | 7.32e-05 | 2 | 177 | 2 | GO:0039020 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | EXOC6 AHI1 CENPE MYO7A FAM91A1 SAR1A SPICE1 MDN1 EXOC6B KIF5A UXT EXOC7 IL4 AP3D1 DNM2 | 7.71e-05 | 546 | 177 | 15 | GO:0051656 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ADCY10 LAMA1 KIF20B SYNGAP1 FEZ2 TET1 PLXNA4 MACF1 ROCK1 KIF5A PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 RASAL1 MOV10 DNM2 NIN | 8.28e-05 | 819 | 177 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | centrosome cycle | 8.79e-05 | 164 | 177 | 8 | GO:0007098 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ADCY10 LAMA1 KIF20B SYNGAP1 FEZ2 TET1 PLXNA4 MACF1 ROCK1 KIF5A PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 RASAL1 MOV10 DNM2 NIN | 9.26e-05 | 826 | 177 | 19 | GO:0048858 |
| GeneOntologyBiologicalProcess | microtubule nucleation | 1.28e-04 | 57 | 177 | 5 | GO:0007020 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | ADCY10 FMR1 FXR2 RNF112 SYNGAP1 PLXNA4 MACF1 SMARCD3 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 NIN | 1.50e-04 | 515 | 177 | 14 | GO:0050767 |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 ADCY10 RANBP2 PHB2 HUWE1 IPO4 IPO9 PMPCA PIK3C3 RGPD3 KCNQ2 MACF1 NUP188 AP3D1 | 1.50e-04 | 515 | 177 | 14 | GO:0072594 |
| GeneOntologyBiologicalProcess | vesicle tethering | 1.56e-04 | 32 | 177 | 4 | GO:0099022 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 1.61e-04 | 179 | 177 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCP110 RIPOR2 GIT1 CENPE CUL9 CHD3 TUBGCP2 SPICE1 CEP350 HAUS8 CCDC88A ROCK1 UXT GOLGA2 CCDC63 DNM2 NIN | 1.62e-04 | 720 | 177 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ADCY10 CCP110 RIPOR2 AHI1 ARHGAP24 FMR1 SYNGAP1 LRIG2 CCDC88A PLXNA4 MACF1 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 MOV10 DNM2 NIN | 1.63e-04 | 863 | 177 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.67e-04 | 13 | 177 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | EXOC6 SAR1A AP5Z1 EXOC6B MACF1 GOLGA5 AP3D1 GOLGA2 CUX1 GOLGA4 DNM2 | 1.74e-04 | 339 | 177 | 11 | GO:0048193 |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 2.11e-04 | 14 | 177 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | pronephros morphogenesis | 2.18e-04 | 3 | 177 | 2 | GO:0072114 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse, modulating synaptic transmission | 2.18e-04 | 3 | 177 | 2 | GO:0099577 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse | 2.18e-04 | 3 | 177 | 2 | GO:0140244 | |
| GeneOntologyBiologicalProcess | pronephric nephron development | 2.18e-04 | 3 | 177 | 2 | GO:0039019 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ADCY10 RIPOR2 MYO7A LAMA1 SYNGAP1 FEZ2 TET1 PLXNA4 MACF1 KIF5A PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 DNM2 NIN | 2.53e-04 | 748 | 177 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | NPHP1 ADCY10 CCP110 RIPOR2 AHI1 FMR1 GIT1 CENPE AZU1 ADGRL1 AR ACE2 CCDC88A PLXNA4 MACF1 ROCK1 MAPK9 IL4 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 DNM2 NIN | 2.71e-04 | 1366 | 177 | 25 | GO:0051130 |
| GeneOntologyBiologicalProcess | negative regulation of small GTPase mediated signal transduction | 2.76e-04 | 67 | 177 | 5 | GO:0051058 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.89e-04 | 195 | 177 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | ADCY10 FMR1 FXR2 RNF112 ADGRL1 SYNGAP1 PLXNA4 MACF1 SMARCD3 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 NIN | 3.34e-04 | 625 | 177 | 15 | GO:0051960 |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane transport | 3.39e-04 | 70 | 177 | 5 | GO:0006893 | |
| GeneOntologyBiologicalProcess | import into nucleus | 3.54e-04 | 201 | 177 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ADCY10 CCP110 RIPOR2 AHI1 ARHGAP24 FMR1 SYNGAP1 LRIG2 CCDC88A PLXNA4 MACF1 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 DNM2 NIN | 3.68e-04 | 846 | 177 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | organelle localization | EXOC6 AHI1 CENPE MYO7A FAM91A1 SAR1A SPICE1 MDN1 EXOC6B KIF5A UXT EXOC7 IL4 AP3D1 GOLGA2 DNM2 | 3.80e-04 | 703 | 177 | 16 | GO:0051640 |
| GeneOntologyBiologicalProcess | cytokinesis | 3.90e-04 | 204 | 177 | 8 | GO:0000910 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RANBP2 FMR1 PHB2 IPO4 YWHAE IPO9 MDN1 RGPD3 KCNQ2 NUP188 | 4.39e-04 | 378 | 177 | 11 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RANBP2 FMR1 PHB2 IPO4 YWHAE IPO9 MDN1 RGPD3 KCNQ2 NUP188 | 4.39e-04 | 378 | 177 | 11 | GO:0006913 |
| GeneOntologyBiologicalProcess | axon development | ADCY10 LAMA1 SYNGAP1 LRIG2 FEZ2 AP5Z1 PLXNA4 MACF1 KIF5A PLXNA1 GOLGA2 PLXNA2 GOLGA4 DNM2 NIN | 4.42e-04 | 642 | 177 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | ADCY10 AHI1 ANXA3 PHB2 HUWE1 AR SYNGAP1 CD34 PLXNA4 MACF1 ROCK1 PRKDC FMNL1 PLXNA1 GOLGA2 PLXNA2 CUX1 GOLGA4 RASAL1 MOV10 NIN | 4.47e-04 | 1090 | 177 | 21 | GO:0022603 |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 5.71e-04 | 119 | 177 | 6 | GO:0006892 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 6.36e-04 | 20 | 177 | 3 | GO:0006607 | |
| GeneOntologyBiologicalProcess | membrane fission | 7.60e-04 | 48 | 177 | 4 | GO:0090148 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | CCP110 RIPOR2 FMR1 CENPE TUBGCP2 AR SPICE1 HAUS8 MDN1 PRKDC MAPK9 GOLGA2 | 8.50e-04 | 475 | 177 | 12 | GO:0140694 |
| GeneOntologyCellularComponent | site of polarized growth | ADCY10 EXOC6 FMR1 GIT1 ADGRL1 YWHAE KIF20B LRIG2 TRPM1 KIF5A EXOC7 DNM2 NIN | 2.77e-07 | 253 | 178 | 13 | GO:0030427 |
| GeneOntologyCellularComponent | growth cone | ADCY10 EXOC6 FMR1 GIT1 ADGRL1 YWHAE KIF20B LRIG2 KIF5A EXOC7 DNM2 NIN | 1.33e-06 | 245 | 178 | 12 | GO:0030426 |
| GeneOntologyCellularComponent | centrosome | CCDC14 CCP110 AHI1 GIT1 CCDC18 ANKRD26 CCDC81 CHD3 TUBGCP2 KIF20B SPICE1 CEP350 HAUS8 CCDC88A CROCC2 HASPIN SLMAP UXT EXOC7 DNM2 NIN | 2.67e-06 | 770 | 178 | 21 | GO:0005813 |
| GeneOntologyCellularComponent | axon | ADCY10 EXOC6 FMR1 GIT1 ANXA3 PHB2 ADGRL1 GRIK4 YWHAE AR KIF20B ADCY8 ITPR2 LRIG2 FEZ2 KCNQ2 TRPM1 KIF5A EXOC7 AP3D1 DNM2 NIN | 7.46e-06 | 891 | 178 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC14 CCP110 AHI1 GIT1 CCDC18 ANKRD26 CCDC81 CHD3 TUBGCP2 KIF20B SPICE1 CEP350 HAUS8 CCDC88A CROCC2 HASPIN SLMAP ROCK1 UXT EXOC7 DNM2 NIN | 1.21e-05 | 919 | 178 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | centriole | 1.72e-05 | 172 | 178 | 9 | GO:0005814 | |
| GeneOntologyCellularComponent | central region of growth cone | 2.07e-05 | 7 | 178 | 3 | GO:0090724 | |
| GeneOntologyCellularComponent | distal axon | ADCY10 EXOC6 FMR1 GIT1 ADGRL1 GRIK4 YWHAE KIF20B LRIG2 KIF5A EXOC7 AP3D1 DNM2 NIN | 2.27e-05 | 435 | 178 | 14 | GO:0150034 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 3.29e-05 | 8 | 178 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 6.97e-05 | 10 | 178 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.63e-04 | 13 | 178 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.06e-04 | 14 | 178 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 4.51e-04 | 18 | 178 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 6.22e-04 | 20 | 178 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 7.21e-04 | 21 | 178 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | exocyst | 7.21e-04 | 21 | 178 | 3 | GO:0000145 | |
| GeneOntologyCellularComponent | kinesin complex | 7.99e-04 | 49 | 178 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | presynaptic endosome | 1.47e-03 | 7 | 178 | 2 | GO:0098830 | |
| GeneOntologyCellularComponent | photoreceptor distal connecting cilium | 1.47e-03 | 7 | 178 | 2 | GO:0120206 | |
| GeneOntologyCellularComponent | glutamatergic synapse | FMR1 GIT1 FXR2 PHB2 ADGRL1 GRIK4 YWHAE ITGB5 ADCY8 ELMO1 SYNGAP1 PIK3C3 PLXNA4 AP3D1 PLXNA1 DNM2 | 1.71e-03 | 817 | 178 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | spindle pole | 1.91e-03 | 205 | 178 | 7 | GO:0000922 | |
| Domain | ARM-type_fold | RIPOR2 MROH2A CUL9 HUWE1 IPO4 ELMO1 ITPR2 ARFGEF3 IPO9 PIK3C3 MROH7 PKP2 PRKDC NUP188 AP3D1 FMNL1 | 1.12e-07 | 339 | 173 | 16 | IPR016024 |
| Domain | ARM-like | RIPOR2 MROH2A CUL9 HUWE1 IPO4 ELMO1 IPO9 AP5Z1 MROH7 PKP2 PRKDC AP3D1 | 8.43e-06 | 270 | 173 | 12 | IPR011989 |
| Domain | - | 4.32e-05 | 222 | 173 | 10 | 1.25.10.10 | |
| Domain | Plexin_cytopl | 6.30e-05 | 9 | 173 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 6.30e-05 | 9 | 173 | 3 | IPR013548 | |
| Domain | Plexin | 6.30e-05 | 9 | 173 | 3 | IPR031148 | |
| Domain | Sec15 | 8.53e-05 | 2 | 173 | 2 | PF04091 | |
| Domain | EXOC6/Sec15 | 8.53e-05 | 2 | 173 | 2 | IPR007225 | |
| Domain | - | 8.94e-05 | 10 | 173 | 3 | 1.10.220.60 | |
| Domain | Grip | 1.22e-04 | 11 | 173 | 3 | SM00755 | |
| Domain | GRIP | 1.22e-04 | 11 | 173 | 3 | PF01465 | |
| Domain | Ran_BP1 | 1.62e-04 | 12 | 173 | 3 | PF00638 | |
| Domain | RANBD1 | 1.62e-04 | 12 | 173 | 3 | PS50196 | |
| Domain | GRIP_dom | 1.62e-04 | 12 | 173 | 3 | IPR000237 | |
| Domain | GRIP | 1.62e-04 | 12 | 173 | 3 | PS50913 | |
| Domain | Rho_GTPase_activation_prot | 1.67e-04 | 88 | 173 | 6 | IPR008936 | |
| Domain | RanBD | 2.09e-04 | 13 | 173 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 2.09e-04 | 13 | 173 | 3 | IPR000156 | |
| Domain | Agenet | 2.54e-04 | 3 | 173 | 2 | PF05641 | |
| Domain | AGENET_LIKE | 2.54e-04 | 3 | 173 | 2 | PS51641 | |
| Domain | FXMRP1_C_core | 2.54e-04 | 3 | 173 | 2 | IPR022034 | |
| Domain | Agenet-like_dom | 2.54e-04 | 3 | 173 | 2 | IPR008395 | |
| Domain | FXMRP1_C_core | 2.54e-04 | 3 | 173 | 2 | PF12235 | |
| Domain | HEAT_REPEAT | 4.79e-04 | 70 | 173 | 5 | PS50077 | |
| Domain | TRPM_tetra | 5.06e-04 | 4 | 173 | 2 | PF16519 | |
| Domain | TRPM_tetra | 5.06e-04 | 4 | 173 | 2 | IPR032415 | |
| Domain | Prefoldin | 5.45e-04 | 72 | 173 | 5 | IPR009053 | |
| Domain | Kinesin_motor_CS | 5.51e-04 | 41 | 173 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 6.62e-04 | 43 | 173 | 4 | IPR027640 | |
| Domain | - | 7.23e-04 | 44 | 173 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 7.23e-04 | 44 | 173 | 4 | PF00225 | |
| Domain | KISc | 7.23e-04 | 44 | 173 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 7.23e-04 | 44 | 173 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 7.23e-04 | 44 | 173 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 7.23e-04 | 44 | 173 | 4 | PS50067 | |
| Domain | PSI | 7.23e-04 | 44 | 173 | 4 | IPR016201 | |
| Domain | PSI | 8.57e-04 | 46 | 173 | 4 | SM00423 | |
| Domain | UDPGT | 9.19e-04 | 21 | 173 | 3 | PF00201 | |
| Domain | UDPGT | 9.19e-04 | 21 | 173 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 9.19e-04 | 21 | 173 | 3 | IPR002213 | |
| Domain | Liprin | 1.25e-03 | 6 | 173 | 2 | IPR029515 | |
| Domain | tRNA-bd_arm | 1.37e-03 | 24 | 173 | 3 | IPR010978 | |
| Domain | Rab_bind | 1.74e-03 | 7 | 173 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.74e-03 | 7 | 173 | 2 | IPR032023 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 NCOA2 CCP110 RANBP2 ARHGAP24 GIT1 CENPE ANKRD26 FAM91A1 EFHD2 YWHAE AR CCDC88A RND1 PIK3C3 RGPD3 TJP2 ROCK1 KIF5A CDC25C FMNL1 PLXNA1 GOLGA2 | 4.28e-08 | 649 | 134 | 23 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | RGPD4 NCOA2 RANBP2 CENPE YWHAE AR PIK3C3 RGPD3 ROCK1 KIF5A CDC25C FMNL1 | 6.13e-06 | 257 | 134 | 12 | MM14755 |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 7.26e-06 | 14 | 134 | 4 | M7578 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | NCOA2 CCP110 RANBP2 ARHGAP24 GIT1 CENPE ANKRD26 FAM91A1 EFHD2 YWHAE AR CCDC88A RND1 PIK3C3 TJP2 ROCK1 KIF5A CDC25C FMNL1 PLXNA1 | 1.48e-05 | 720 | 134 | 20 | M41838 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 6.01e-05 | 23 | 134 | 4 | MM15216 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 6.77e-05 | 9 | 134 | 3 | MM15030 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.19e-04 | 51 | 134 | 5 | MM14967 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | NCOA2 NPHP1 EXOC6 CCP110 CRTC3 AHI1 YWHAE HAUS8 PPARGC1B SMARCD3 EXOC7 | 1.25e-04 | 297 | 134 | 11 | M27050 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | CCP110 ARHGAP24 GIT1 ANKRD26 FAM91A1 EFHD2 CCDC88A RND1 TJP2 ROCK1 FMNL1 PLXNA1 GOLGA2 | 2.80e-04 | 439 | 134 | 13 | MM15595 |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 2.83e-04 | 14 | 134 | 3 | MM15029 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.50e-04 | 64 | 134 | 5 | M7923 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 3.51e-04 | 15 | 134 | 3 | MM15031 | |
| Pubmed | RGPD4 NCOA2 RANBP2 ARHGAP24 FMR1 GIT1 CENPE FXR2 PHB2 EFHD2 HUWE1 IPO4 YWHAE SPICE1 SYNGAP1 LRIG2 PPP1R7 CCDC88A MDN1 RGPD3 ZBTB21 MACF1 ROCK1 KIF5A FRMPD3 GOLGA2 CUX1 GOLGA4 GOLGB1 RASAL1 DNM2 | 5.61e-16 | 963 | 182 | 31 | 28671696 | |
| Pubmed | EXOC6 GIT1 PPFIBP1 CCDC18 PSMD12 TUBGCP2 SPICE1 CEP350 ARFGEF3 PHKA1 HAUS8 CCDC88A PIK3C3 SLMAP GOLGA5 DNM2 NIN | 2.70e-14 | 251 | 182 | 17 | 29778605 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 CRTC3 GIT1 PPFIBP1 CCDC18 ANKRD26 YWHAE REEP2 MAP3K3 SPICE1 CEP350 ARFGEF3 HAUS8 CCDC88A IPO9 MDN1 PIK3C3 TET1 ZBTB21 PKP2 TJP2 MACF1 CDC25C UTRN GOLGA4 GOLGB1 | 6.78e-13 | 861 | 182 | 26 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOA2 CCP110 KRT14 GIT1 CENPE ANKRD26 CUL9 HUWE1 TUBGCP2 IPO4 LDHB KIF20B ARFGEF3 CCDC88A PRDX3 MACF1 ROCK1 MAPK9 GOLGA2 GOLGB1 CDCA4 NIN | 7.14e-13 | 588 | 182 | 22 | 38580884 |
| Pubmed | CCDC14 RANBP2 CRTC3 KRT14 RIPOR2 ARID4B ADGRL1 YWHAE MAP3K3 CEP350 RGL1 CCDC88A MACF1 OS9 KIF5A PRKDC MAPK9 GOLGA2 CUX1 GOLGB1 | 1.51e-12 | 486 | 182 | 20 | 20936779 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NPHP1 EXOC6 CCP110 CRTC3 AHI1 GIT1 MYO7A PPFIBP1 PHB2 MRPS35 PSMD12 IPO4 YWHAE EXOSC2 MAP3K3 PPP1R7 HAUS8 CCDC88A IPO9 PRDX3 ZBTB21 MARF1 EXOC6B SF3A3 UXT GOLGA5 EXOC7 CDC25C MOV10 DNM2 | 1.30e-11 | 1321 | 182 | 30 | 27173435 |
| Pubmed | RANBP2 FMR1 GIT1 CENPE FXR2 MED16 PSMD12 HUWE1 TUBGCP2 IPO4 LDHB YWHAE ELMO1 ITPR2 CEP350 IPO9 MDN1 PIK3C3 MARF1 KIF5A PRKDC NUP188 GOLGA5 EXOC7 DNAJC3 AP3D1 FMNL1 GOLGB1 | 1.96e-11 | 1168 | 182 | 28 | 19946888 | |
| Pubmed | KRT14 MYO7A FXR2 PPFIBP1 MROH2A MRPS35 CUL9 PSMD12 HUWE1 ITGB5 AR MAP3K3 PIK3C3 CROCC2 MROH7 UGT2B17 MACF1 MYO18B | 1.61e-10 | 496 | 182 | 18 | 31343991 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RANBP2 FXR2 ANXA3 AZU1 ACP3 MRPS35 EFHD2 PSMD12 HUWE1 IPO4 YWHAE LRIG2 PMPCA SF3A3 TJP2 OS9 KIF5A PRKDC NUP188 MAPK9 CDC25C PADI2 UTRN DNAJC3 | 3.56e-10 | 974 | 182 | 24 | 28675297 |
| Pubmed | KRT14 PPFIBP1 ANKRD26 FAM91A1 HUWE1 IPO4 SAR1A LDHB CEP350 LRIG2 ARFGEF3 CCDC88A PKP2 TJP2 RHBDD3 PRKDC GOLGA5 AP3D1 CUX1 GOLGA4 GOLGB1 | 9.62e-10 | 777 | 182 | 21 | 35844135 | |
| Pubmed | CCDC14 RANBP2 KRT14 CCDC18 FAM91A1 PSMD12 HUWE1 YWHAE SPICE1 ITPR2 CEP350 PPP1R7 PHKA1 CCDC88A IPO9 PMPCA ROCK1 UXT GOLGA5 MAPK9 CDC25C UTRN GOLGA4 NIN | 1.54e-09 | 1049 | 182 | 24 | 27880917 | |
| Pubmed | CCDC14 NCOA2 CCP110 ARID4B GIT1 MED16 CCDC18 PHB2 ANKRD26 FAM91A1 HUWE1 SPICE1 CEP350 HAUS8 IPO9 ROCK1 KIF5A UTRN NIN | 1.57e-09 | 645 | 182 | 19 | 25281560 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYO7A PHB2 CHD3 PSMD12 SAR1A LDHB YWHAE IPO9 MDN1 SF3A3 ADAMTS20 MACF1 SMARCD3 ROCK1 KIF5A PRKDC EXOC7 UTRN AP3D1 GOLGB1 DNM2 | 4.40e-09 | 847 | 182 | 21 | 35235311 |
| Pubmed | CCP110 CENPE FXR2 EFHD2 PSMD12 HUWE1 TUBGCP2 SAR1A ITPR2 CEP350 HAUS8 CCDC88A SF3A3 TJP2 OS9 ROCK1 GOLGA5 EXOC7 GOLGA4 | 1.24e-08 | 733 | 182 | 19 | 34672954 | |
| Pubmed | CCP110 CRTC3 PPFIBP1 ANKRD26 TUBGCP2 YWHAE SPICE1 SLMAP PKP2 TJP2 PRKDC CDC25C UTRN FMNL1 NIN | 1.58e-08 | 446 | 182 | 15 | 24255178 | |
| Pubmed | CCDC14 PPFIBP1 ACP3 MRPS35 EFHD2 PSMD12 TUBGCP2 IPO4 LDHB KIF20B CEP350 IPO9 MDN1 TRPM3 CROCC2 ZBTB21 ROCK1 DNAJC3 | 2.72e-08 | 689 | 182 | 18 | 36543142 | |
| Pubmed | RANBP2 DHX58 FXR2 PPFIBP1 PHB2 MRPS35 PSMD12 HUWE1 TUBGCP2 IPO4 YWHAE EXOSC2 ITPR2 ARFGEF3 IPO9 MDN1 PRDX3 SF3A3 TJP2 OS9 PRKDC NUP188 EXOC7 AP3D1 CUX1 MOV10 | 3.90e-08 | 1440 | 182 | 26 | 30833792 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | CRTC3 TUBGCP2 EXOSC2 CEP350 MDN1 PMPCA PKP2 OS9 GOLGA2 GOLGB1 MOV10 NIN | 6.55e-08 | 298 | 182 | 12 | 32353859 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | SETD1A LAMA1 CUL9 FAM91A1 HUWE1 TUBGCP2 IPO4 ARFGEF3 IPO9 PMPCA SF3A3 UTRN | 1.11e-07 | 313 | 182 | 12 | 38270169 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCDC14 RANBP2 GIT1 CENPE FXR2 PPFIBP1 ANKRD26 FAM91A1 EFHD2 TUBGCP2 EXOSC2 CEP350 PPP1R7 HAUS8 CCDC88A TJP2 GOLGA5 RMC1 NIN | 1.33e-07 | 853 | 182 | 19 | 28718761 |
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 18625214 | ||
| Pubmed | Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. | 1.41e-07 | 3 | 182 | 3 | 18302198 | |
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 27397516 | ||
| Pubmed | RGPD4 RANBP2 FMR1 GIT1 FXR2 PHB2 MRPS35 ADGRL1 FAM91A1 PSMD12 HUWE1 LDHB YWHAE REEP2 SYNGAP1 ARFGEF3 CCDC88A RGPD3 TJP2 KCNQ2 MACF1 RASAL1 | 1.52e-07 | 1139 | 182 | 22 | 36417873 | |
| Pubmed | 1.54e-07 | 76 | 182 | 7 | 27542412 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RANBP2 FXR2 MRPS35 EFHD2 PSMD12 HUWE1 IPO4 LDHB YWHAE EXOSC2 PPP1R7 PHKA1 IPO9 MDN1 PRDX3 SF3A3 MACF1 PRKDC EXOC7 AP3D1 MOV10 DNM2 | 1.77e-07 | 1149 | 182 | 22 | 35446349 |
| Pubmed | PPFIBP1 PHB2 FAM91A1 EFHD2 LDHB ITGB5 CCDC88A GOLGA5 FMNL1 GOLGA4 GOLGB1 FILIP1L | 2.63e-07 | 339 | 182 | 12 | 37232246 | |
| Pubmed | RGPD4 RANBP2 CHD3 HUWE1 KIF20B CCDC88A RGPD3 TET1 ZBTB21 GOLGA5 UTRN CUX1 GOLGB1 | 3.61e-07 | 418 | 182 | 13 | 34709266 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CCP110 CRTC3 FXR2 PPFIBP1 TUBGCP2 EXOSC2 CEP350 PPP1R7 MDN1 PMPCA PKP2 OS9 GOLGA2 CUX1 GOLGB1 MOV10 NIN | 5.33e-07 | 754 | 182 | 17 | 33060197 |
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 5.62e-07 | 4 | 182 | 3 | 25518740 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 15718469 | ||
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 11306810 | ||
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 18281521 | ||
| Pubmed | 9.47e-07 | 15 | 182 | 4 | 14697343 | ||
| Pubmed | KRT14 CHD3 PSMD12 LDHB YWHAE KRT24 IPO9 MDN1 MACF1 FRMPD3 MYO18B UTRN GOLGA2 MOV10 | 1.07e-06 | 538 | 182 | 14 | 28524877 | |
| Pubmed | 1.09e-06 | 101 | 182 | 7 | 10997877 | ||
| Pubmed | 1.10e-06 | 146 | 182 | 8 | 21399614 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 RANBP2 KRT14 FMR1 FXR2 PPFIBP1 EFHD2 SAR1A YWHAE ITPR2 RGPD3 PKP2 TJP2 PRKDC CUX1 | 1.21e-06 | 626 | 182 | 15 | 33644029 |
| Pubmed | CCP110 PPFIBP1 PHB2 ANKRD26 FAM91A1 SAR1A CCDC88A PKP2 MACF1 GOLGA5 PLXNA1 CUX1 GOLGB1 | 1.25e-06 | 467 | 182 | 13 | 30194290 | |
| Pubmed | A molecular network for the transport of the TI-VAMP/VAMP7 vesicles from cell center to periphery. | 1.40e-06 | 5 | 182 | 3 | 22705394 | |
| Pubmed | RANBP2 ANKRD26 YWHAE CCDC88A MACF1 GOLGA5 UTRN AP3D1 GOLGA2 GOLGB1 | 1.41e-06 | 263 | 182 | 10 | 34702444 | |
| Pubmed | 1.42e-06 | 151 | 182 | 8 | 17043677 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RANBP2 KRT14 GIT1 FXR2 RPP40 PPFIBP1 PHB2 MRPS35 FAM91A1 EFHD2 HUWE1 LDHB YWHAE EXOSC2 PRDX3 SF3A3 MACF1 PRKDC UXT AP3D1 GOLGA2 GOLGA4 GOLGB1 | 1.55e-06 | 1415 | 182 | 23 | 28515276 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.56e-06 | 153 | 182 | 8 | 26365490 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 RANBP2 ANXA3 PSMD12 HUWE1 IPO4 SAR1A LDHB YWHAE IPO9 MDN1 PRKDC EXOC7 MOV10 DNM2 | 1.82e-06 | 647 | 182 | 15 | 26618866 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | NPHP1 CCP110 KRT14 AHI1 PHB2 EFHD2 LDHB YWHAE IPO9 EXOC6B PRKDC NUP188 GOLGA4 GOLGB1 | 1.85e-06 | 564 | 182 | 14 | 21565611 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CENPE MYO7A FXR2 RNF112 LAMA1 HUWE1 ITPR2 PPP1R7 MDN1 ZBED4 TRPM3 PLXNA4 PRKDC NUP188 MAPK9 UTRN | 1.87e-06 | 736 | 182 | 16 | 29676528 |
| Pubmed | RANBP2 FMR1 FXR2 CUL9 PSMD12 HUWE1 IPO4 MDN1 TJP2 MACF1 PRKDC NUP188 UTRN MOV10 DNM2 | 2.03e-06 | 653 | 182 | 15 | 22586326 | |
| Pubmed | RGPD4 RANBP2 KRT14 PHB2 ANKRD26 MRPS35 CHD3 RND1 MDN1 ZBED4 PMPCA RGPD3 ZBTB21 MARF1 PLXNA4 MACF1 KIF5A PRKDC DNAJC3 AP3D1 PLXNA2 CUX1 GOLGB1 | 2.13e-06 | 1442 | 182 | 23 | 35575683 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | DHX58 ANXA3 HUWE1 LDHB YWHAE IPO9 MDN1 PRDX3 PRKDC MOV10 DNM2 | 2.25e-06 | 344 | 182 | 11 | 30333137 |
| Pubmed | RANBP2 FMR1 GIT1 ANKRD26 YWHAE ITGB5 PPP1R7 SLMAP MACF1 OS9 MYO18B UTRN DNM2 | 2.47e-06 | 497 | 182 | 13 | 23414517 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANBP2 CHD3 PSMD12 HUWE1 TUBGCP2 YWHAE IPO9 MDN1 SF3A3 MACF1 PRKDC EXOC7 GOLGB1 DNM2 | 2.66e-06 | 582 | 182 | 14 | 20467437 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | EXOC6 FMR1 ARID4B CENPE FXR2 MED16 CHD3 EXOSC2 KIF20B MDN1 PIK3C3 MACF1 PRKDC EXOC7 AP3D1 MOV10 | 2.77e-06 | 759 | 182 | 16 | 35915203 |
| Pubmed | 2.89e-06 | 285 | 182 | 10 | 32838362 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT14 FMR1 FXR2 PPFIBP1 ANXA3 PHB2 MRPS35 TUBGCP2 IPO4 LDHB YWHAE EXOSC2 KIF20B ITPR2 SLMAP SF3A3 PKP2 TJP2 PRKDC GOLGA2 MOV10 | 3.00e-06 | 1257 | 182 | 21 | 36526897 |
| Pubmed | 3.55e-06 | 78 | 182 | 6 | 25720964 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CENPE FXR2 PPFIBP2 ISLR SBK1 ARFGEF3 TJP2 MACF1 PRKDC MYO18B FMNL1 | 3.56e-06 | 361 | 182 | 11 | 26167880 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1A RANBP2 FMR1 GIT1 FXR2 MED16 HUWE1 ITPR2 HASPIN PKP2 NUP188 MOV10 | 3.98e-06 | 440 | 182 | 12 | 34244565 |
| Pubmed | EXOC6 CCP110 RANBP2 FXR2 FAM91A1 HUWE1 TUBGCP2 IPO4 HAUS8 MDN1 PMPCA PRDX3 EXOC7 DNM2 | 4.22e-06 | 606 | 182 | 14 | 36538041 | |
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 9037092 | ||
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 4.86e-06 | 7 | 182 | 3 | 19655386 | |
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 15004235 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 21205196 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 24403063 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 23536549 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 12191015 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 22821000 | ||
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 4.86e-06 | 7 | 182 | 3 | 19063725 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.86e-06 | 7 | 182 | 3 | 11353387 | |
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 30944974 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.86e-06 | 7 | 182 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.86e-06 | 7 | 182 | 3 | 17372272 | |
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 38657106 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 18949001 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 25187515 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 8603673 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 26632511 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 23818861 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 20682751 | ||
| Pubmed | PHB2 FAM91A1 PSMD12 HUWE1 IPO4 YWHAE IPO9 PRKDC GOLGA5 UTRN AP3D1 GOLGB1 | 4.89e-06 | 449 | 182 | 12 | 31732153 | |
| Pubmed | RANBP2 PPFIBP1 PHB2 ANKRD26 PSMD12 YWHAE SPICE1 CCDC88A PKP2 MACF1 ROCK1 PRKDC AP3D1 GOLGA4 GOLGB1 | 5.40e-06 | 708 | 182 | 15 | 39231216 | |
| Pubmed | 5.68e-06 | 182 | 182 | 8 | 15102471 | ||
| Pubmed | SETD1A RANBP2 KRT14 FXR2 PHB2 MRPS35 PSMD12 IPO4 TJP2 MACF1 PRKDC UTRN GOLGA2 GOLGB1 DNM2 | 5.68e-06 | 711 | 182 | 15 | 33022573 | |
| Pubmed | 5.91e-06 | 183 | 182 | 8 | 23956138 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | FMR1 FXR2 MRPS35 EFHD2 CHD3 PSMD12 SAR1A LDHB YWHAE PRDX3 SF3A3 TJP2 PRKDC AP3D1 MOV10 | 5.97e-06 | 714 | 182 | 15 | 28302793 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | CRTC3 PPFIBP1 MRPS35 CUL9 HUWE1 TUBGCP2 YWHAE SPICE1 CEP350 PHKA1 CCDC88A PKP2 PRKDC MOV10 | 7.70e-06 | 639 | 182 | 14 | 23443559 |
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 7.74e-06 | 8 | 182 | 3 | 22368082 | |
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 15661641 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 7.74e-06 | 8 | 182 | 3 | 21670213 | |
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 7.74e-06 | 8 | 182 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 7.74e-06 | 8 | 182 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 7.74e-06 | 8 | 182 | 3 | 28745977 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 KRT14 CHD3 HUWE1 SAR1A YWHAE ITPR2 CEP350 MDN1 PRDX3 ZBTB21 SF3A3 TJP2 MACF1 PRKDC NUP188 UTRN GOLGB1 | 8.06e-06 | 1024 | 182 | 18 | 24711643 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SETD1A RANBP2 FXR2 CHD3 MDN1 PRDX3 PRKDC EXOC7 UTRN CUX1 DNM2 | 8.14e-06 | 394 | 182 | 11 | 27248496 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 9.01e-06 | 256 | 182 | 9 | 33397691 | |
| Pubmed | RANBP2 RPP40 PSMD12 HUWE1 LDHB YWHAE EXOSC2 CCDC88A MDN1 SLMAP PRKDC | 9.16e-06 | 399 | 182 | 11 | 37536630 | |
| Pubmed | RANBP2 FMR1 FXR2 RPP40 CHD3 LDHB YWHAE EXOSC2 MDN1 PRDX3 SF3A3 TJP2 PRKDC GOLGA2 CUX1 MOV10 | 1.09e-05 | 847 | 182 | 16 | 35850772 | |
| Pubmed | RANBP2 PSMD12 HUWE1 TUBGCP2 SAR1A RHBDD3 KIF5A PRKDC NUP188 EXOC7 GOLGA2 | 1.13e-05 | 408 | 182 | 11 | 33766124 | |
| Interaction | PCNT interactions | CCDC14 SETD1A FMR1 CCDC18 CHD3 HUWE1 TUBGCP2 SPICE1 SYNGAP1 CEP350 IPO9 MACF1 UTRN DNM2 NIN | 4.32e-09 | 241 | 179 | 15 | int:PCNT |
| Interaction | KRT18 interactions | CCDC14 CCP110 KRT14 FXR2 CCDC18 ANKRD26 HUWE1 YWHAE AR SPICE1 CEP350 ACE2 HAUS8 PRDX3 PKP2 NUP188 DNAJC3 GOLGA2 NIN | 6.75e-09 | 419 | 179 | 19 | int:KRT18 |
| Interaction | YWHAH interactions | NCOA2 CCP110 CRTC3 GIT1 FXR2 PPFIBP2 PPFIBP1 CCDC18 ANKRD26 HUWE1 YWHAE REEP2 MAP3K3 SYNGAP1 CEP350 ARFGEF3 HAUS8 CCDC88A IPO9 PIK3C3 TET1 ZBTB21 PKP2 TJP2 MACF1 KIF5A CDC25C UTRN GOLGA4 NIN | 3.94e-08 | 1102 | 179 | 30 | int:YWHAH |
| Interaction | MED4 interactions | CCDC14 CCP110 AHI1 GIT1 CENPE MED16 CCDC18 ANKRD26 FAM91A1 HUWE1 AR SPICE1 CEP350 HAUS8 KIF5A UXT UTRN NIN | 1.15e-07 | 450 | 179 | 18 | int:MED4 |
| Interaction | CAMSAP2 interactions | CCP110 FMR1 YWHAE SPICE1 SYNGAP1 CEP350 ZBTB21 MACF1 CDC25C DNAJC3 NIN | 3.42e-07 | 169 | 179 | 11 | int:CAMSAP2 |
| Interaction | PCM1 interactions | CCDC14 CCP110 KRT14 AHI1 FMR1 CENPE FXR2 CCDC18 ANKRD26 YWHAE AR SPICE1 CEP350 HAUS8 KRT24 GOLGA2 NIN | 3.53e-07 | 434 | 179 | 17 | int:PCM1 |
| Interaction | ATG16L1 interactions | CCDC14 CCP110 RANBP2 FMR1 MED16 INPP5D TMEM74 PHB2 EFHD2 TUBGCP2 IPO4 LDHB YWHAE ITGB5 ELMO1 SPICE1 ITPR2 CEP350 ARFGEF3 CCDC88A IPO9 PIK3C3 PKP2 FMNL1 GOLGA2 PLXNA2 GOLGB1 MOV10 DNM2 | 4.17e-07 | 1161 | 179 | 29 | int:ATG16L1 |
| Interaction | YWHAG interactions | CCP110 CRTC3 RIPOR2 GIT1 PPFIBP2 PPFIBP1 CCDC18 ANKRD26 HUWE1 LDHB YWHAE REEP2 MAP3K3 SPICE1 SYNGAP1 CEP350 HAUS8 CCDC88A IPO9 MDN1 PIK3C3 TET1 ZBTB21 PKP2 TJP2 MACF1 KIF5A PRKDC CDC25C UTRN | 5.75e-07 | 1248 | 179 | 30 | int:YWHAG |
| Interaction | CPAP interactions | CCP110 CRTC3 YWHAE SPICE1 HAUS8 IPO9 SLMAP TJP2 AP3D1 MOV10 NIN | 7.16e-07 | 182 | 179 | 11 | int:CPAP |
| Interaction | CEP135 interactions | CCDC14 CCP110 CCDC18 ANKRD26 KIF20B SPICE1 CEP350 HAUS8 CCDC88A PKP2 TJP2 GOLGB1 NIN | 1.01e-06 | 272 | 179 | 13 | int:CEP135 |
| Interaction | KRT5 interactions | NPHP1 KRT14 AHI1 ARHGAP24 CHD3 ACE2 KRT24 RND1 LRRC31 PKP2 NIN | 1.28e-06 | 193 | 179 | 11 | int:KRT5 |
| Interaction | VPS33B interactions | PPFIBP1 CCDC18 PSMD12 SPICE1 CEP350 ARFGEF3 CCDC88A SLMAP GOLGA5 AP3D1 NIN | 1.73e-06 | 199 | 179 | 11 | int:VPS33B |
| Interaction | NDEL1 interactions | FXR2 CCDC18 ANKRD26 YWHAE KIF20B CCDC88A PKP2 KIF5A UTRN GOLGA2 | 2.14e-06 | 164 | 179 | 10 | int:NDEL1 |
| Interaction | KRT8 interactions | CCDC14 CCP110 KRT14 CCDC18 ANKRD26 CHD3 YWHAE AR SPICE1 CEP350 HAUS8 KRT24 IPO9 NUP188 CUX1 NIN | 2.15e-06 | 441 | 179 | 16 | int:KRT8 |
| Interaction | CALM1 interactions | CCDC14 CCP110 RANBP2 MYO7A PSMD12 HUWE1 YWHAE AR ADCY8 PHKA1 ACE2 CCDC88A ZBED4 PIK3C3 PRDX3 KCNQ2 GRAMD1C UTRN MOV10 | 3.26e-06 | 626 | 179 | 19 | int:CALM1 |
| Interaction | GSK3A interactions | CCP110 FMR1 FXR2 PPFIBP1 YWHAE AR SPICE1 CEP350 ARFGEF3 CCDC88A MDN1 MACF1 PRKDC UTRN AP3D1 NIN | 4.13e-06 | 464 | 179 | 16 | int:GSK3A |
| Interaction | AMOT interactions | CCDC14 CCP110 KRT14 ARHGAP24 CCDC18 ANKRD26 SPICE1 CEP350 ACE2 KRT24 SLMAP TJP2 NIN | 4.57e-06 | 312 | 179 | 13 | int:AMOT |
| Interaction | YWHAZ interactions | CCP110 CRTC3 RIPOR2 GIT1 PPFIBP2 PPFIBP1 CCDC18 ANKRD26 HUWE1 LDHB YWHAE REEP2 AR MAP3K3 SYNGAP1 ACE2 CCDC88A KRT24 IPO9 PIK3C3 ZBTB21 PKP2 TJP2 MACF1 KIF5A CDC25C PADI2 MOV10 NIN | 5.33e-06 | 1319 | 179 | 29 | int:YWHAZ |
| Interaction | EXOC1 interactions | 5.40e-06 | 143 | 179 | 9 | int:EXOC1 | |
| Interaction | RPGRIP1L interactions | NPHP1 CCP110 YWHAE SPICE1 CEP350 HAUS8 IPO9 EXOC6B PKP2 GOLGA4 NIN | 5.64e-06 | 225 | 179 | 11 | int:RPGRIP1L |
| Interaction | GOLGA1 interactions | CCP110 CCDC18 ANKRD26 FAM91A1 CEP350 ARFGEF3 MACF1 GOLGA5 GOLGA4 GOLGB1 | 5.71e-06 | 183 | 179 | 10 | int:GOLGA1 |
| Interaction | HECTD1 interactions | EXOC6 FMR1 ARID4B CENPE FXR2 MED16 PHB2 CHD3 PSMD12 HUWE1 YWHAE EXOSC2 KIF20B MDN1 LRRC31 PIK3C3 MACF1 PRKDC EXOC7 CDC25C UTRN AP3D1 MOV10 NIN | 6.96e-06 | 984 | 179 | 24 | int:HECTD1 |
| Interaction | ATOH1 interactions | 7.14e-06 | 80 | 179 | 7 | int:ATOH1 | |
| Interaction | ANAPC2 interactions | CCP110 CCDC18 ANKRD26 CUL9 TUBGCP2 LDHB CEP350 KIF5A PRKDC CUX1 DNM2 | 8.19e-06 | 234 | 179 | 11 | int:ANAPC2 |
| Interaction | DCTN1 interactions | AHI1 CENPE HUWE1 SAR1A YWHAE SPICE1 CEP350 HAUS8 CCDC88A IPO9 SF3A3 TJP2 MACF1 MOV10 DNM2 NIN | 9.78e-06 | 497 | 179 | 16 | int:DCTN1 |
| Interaction | CEP250 interactions | PPFIBP1 CCDC18 MRPS35 HUWE1 YWHAE SPICE1 SYNGAP1 CEP350 CCDC88A PKP2 MOV10 NIN | 1.04e-05 | 287 | 179 | 12 | int:CEP250 |
| Interaction | KDM1A interactions | SOX6 CCDC14 RANBP2 FMR1 CHD3 HUWE1 AR KIF20B SPICE1 CEP350 ACE2 CCDC88A TET1 ZBTB21 SF3A3 GOLGA5 EXOC7 UTRN GOLGA2 CUX1 GOLGB1 CDCA4 NIN | 1.06e-05 | 941 | 179 | 23 | int:KDM1A |
| Interaction | SYNE3 interactions | CCDC14 CCP110 RANBP2 CENPE CCDC18 ANKRD26 REEP2 SPICE1 CEP350 HAUS8 SLMAP PKP2 MACF1 DNAJC3 NIN | 1.06e-05 | 444 | 179 | 15 | int:SYNE3 |
| Interaction | TNFSF13B interactions | 1.12e-05 | 119 | 179 | 8 | int:TNFSF13B | |
| Interaction | STX6 interactions | PPFIBP1 TMEM74 ANKRD26 FAM91A1 CCDC88A RND1 MACF1 GOLGA5 UTRN AP3D1 GOLGA2 CUX1 GOLGA4 GOLGB1 MOV10 | 1.18e-05 | 448 | 179 | 15 | int:STX6 |
| Interaction | PFN1 interactions | RANBP2 ARHGAP24 ANKRD26 AR CEP350 PHKA1 ACE2 PRDX3 SLMAP TJP2 MACF1 FMNL1 GOLGA2 GOLGA4 GOLGB1 DNM2 | 1.31e-05 | 509 | 179 | 16 | int:PFN1 |
| Interaction | CDC42 interactions | FMR1 GIT1 PPFIBP1 PHB2 ANKRD26 ADGRL1 FAM91A1 PSMD12 HUWE1 IPO4 SAR1A YWHAE ITPR2 ARFGEF3 CCDC88A IPO9 MDN1 PRDX3 PKP2 ROCK1 PRKDC GOLGA5 MAPK9 UTRN AP3D1 FMNL1 PLXNA1 GOLGB1 | 1.60e-05 | 1323 | 179 | 28 | int:CDC42 |
| Interaction | YWHAE interactions | CRTC3 AHI1 GIT1 CENPE PPFIBP2 PPFIBP1 CCDC18 ANKRD26 EFHD2 HUWE1 LDHB YWHAE REEP2 MAP3K3 SYNGAP1 ACE2 CCDC88A IPO9 TET1 ZBTB21 PKP2 TJP2 MACF1 ROCK1 KIF5A CDC25C NIN | 1.76e-05 | 1256 | 179 | 27 | int:YWHAE |
| Interaction | S100A2 interactions | CCDC14 CRTC3 ARID4B TMEM69 TIGD1 PSMD12 SPICE1 CEP350 HAUS8 CCDC88A ZBED4 HASPIN ZBTB21 KIF5A | 1.98e-05 | 412 | 179 | 14 | int:S100A2 |
| Interaction | BIN1 interactions | 2.02e-05 | 129 | 179 | 8 | int:BIN1 | |
| Interaction | CCDC14 interactions | 2.02e-05 | 129 | 179 | 8 | int:CCDC14 | |
| Interaction | FBXO42 interactions | CCP110 KRT14 CENPE KIF20B ARFGEF3 CCDC88A MACF1 ROCK1 MAPK9 GOLGA2 GOLGB1 | 2.11e-05 | 259 | 179 | 11 | int:FBXO42 |
| Interaction | GTSE1 interactions | 2.33e-05 | 215 | 179 | 10 | int:GTSE1 | |
| Interaction | SEMA5A interactions | 2.35e-05 | 7 | 179 | 3 | int:SEMA5A | |
| Interaction | NDC80 interactions | CCDC14 CCP110 CENPE CCDC18 ANKRD26 SPICE1 CEP350 HAUS8 ROCK1 DNAJC3 GOLGA2 NIN | 2.38e-05 | 312 | 179 | 12 | int:NDC80 |
| Interaction | RNF43 interactions | RANBP2 FXR2 ANKRD26 YWHAE CCDC88A MACF1 NUP188 GOLGA5 UTRN AP3D1 GOLGA2 GOLGB1 MOV10 DNM2 | 2.94e-05 | 427 | 179 | 14 | int:RNF43 |
| Interaction | CTNNB1 interactions | SOX6 NCOA2 RANBP2 HNF1B ARHGAP24 FMR1 MYO7A PHB2 ANKRD26 HUWE1 LDHB YWHAE AR SYNGAP1 CCDC88A RND1 PKP2 TJP2 PRKDC MAPK9 UTRN CUX1 MOV10 | 3.20e-05 | 1009 | 179 | 23 | int:CTNNB1 |
| Interaction | CHAF1A interactions | RANBP2 ARID4B CHD3 HUWE1 IPO4 YWHAE ACE2 MDN1 SF3A3 TJP2 PRKDC UXT | 3.24e-05 | 322 | 179 | 12 | int:CHAF1A |
| Interaction | CEP63 interactions | 3.27e-05 | 179 | 179 | 9 | int:CEP63 | |
| Interaction | PRNP interactions | CCDC14 PPFIBP2 PPFIBP1 ACP3 MRPS35 EFHD2 PSMD12 TUBGCP2 IPO4 LDHB YWHAE KIF20B CEP350 ACE2 IPO9 MDN1 TRPM3 CROCC2 PRDX3 HASPIN ZBTB21 TJP2 MACF1 ROCK1 DNAJC3 | 3.47e-05 | 1158 | 179 | 25 | int:PRNP |
| Interaction | SAP130 interactions | 3.57e-05 | 181 | 179 | 9 | int:SAP130 | |
| Interaction | UNC45A interactions | NPHP1 CCP110 AHI1 ARHGAP24 HUWE1 LDHB LRRC31 ROCK1 PRKDC NIN | 3.84e-05 | 228 | 179 | 10 | int:UNC45A |
| Interaction | AFDN interactions | PPFIBP1 ANKRD26 YWHAE CCDC88A ZBTB21 PKP2 TJP2 MACF1 ROCK1 UTRN GOLGB1 NIN | 4.48e-05 | 333 | 179 | 12 | int:AFDN |
| Interaction | PXN interactions | CCP110 GIT1 CCDC18 AR SPICE1 CEP350 MACF1 ROCK1 GOLGA4 GOLGB1 MOV10 NIN | 4.62e-05 | 334 | 179 | 12 | int:PXN |
| Interaction | H2BC9 interactions | ARHGAP24 PPFIBP2 LAMA1 CUL9 HPSE2 CHD3 REEP2 CEP350 IPO9 CXorf58 TRPM1 KIF5A GOLGA2 CCDC63 | 4.71e-05 | 446 | 179 | 14 | int:H2BC9 |
| Interaction | RAB2A interactions | PPFIBP1 PHB2 FAM91A1 SAR1A ITGB5 SPICE1 SYNGAP1 ARFGEF3 CCDC88A PKP2 ROCK1 GOLGA5 GOLGA2 GOLGA4 GOLGB1 NIN | 4.84e-05 | 567 | 179 | 16 | int:RAB2A |
| Interaction | KRT2 interactions | NPHP1 CCP110 KRT14 AHI1 ARHGAP24 CHD3 CEP350 ACE2 KRT24 LRRC31 | 5.14e-05 | 236 | 179 | 10 | int:KRT2 |
| Interaction | OBSL1 interactions | RANBP2 KRT14 FXR2 PPFIBP1 TMEM74 MRPS35 CUL9 PSMD12 HUWE1 YWHAE AR MDN1 CROCC2 PRDX3 SF3A3 TJP2 MACF1 PRKDC NUP188 UTRN GOLGB1 | 5.36e-05 | 902 | 179 | 21 | int:OBSL1 |
| Interaction | RAB35 interactions | NPHP1 PPFIBP1 ANKRD26 FAM91A1 EFHD2 SPICE1 ARFGEF3 ACE2 CCDC88A PKP2 MACF1 ROCK1 GOLGA5 UTRN PLXNA1 GOLGB1 | 5.49e-05 | 573 | 179 | 16 | int:RAB35 |
| Interaction | YWHAQ interactions | CCP110 CRTC3 PPFIBP2 PPFIBP1 CCDC18 ANKRD26 LDHB YWHAE AR MAP3K3 CEP350 ACE2 CCDC88A IPO9 PIK3C3 TET1 ZBTB21 PKP2 TJP2 MACF1 KIF5A PRKDC CDC25C GOLGB1 | 5.52e-05 | 1118 | 179 | 24 | int:YWHAQ |
| Interaction | CNTRL interactions | 5.88e-05 | 193 | 179 | 9 | int:CNTRL | |
| Interaction | RHOA interactions | RIPOR2 PPFIBP1 ANKRD26 ADGRL1 IPO4 ITPR2 ACE2 CCDC88A IPO9 MDN1 PIK3C3 SLMAP MARF1 PKP2 TJP2 MACF1 ROCK1 PRKDC GOLGA5 UTRN FMNL1 PLXNA1 GOLGA4 GOLGB1 DNM2 | 6.10e-05 | 1199 | 179 | 25 | int:RHOA |
| Interaction | CDC25A interactions | 6.25e-05 | 151 | 179 | 8 | int:CDC25A | |
| Interaction | LCK interactions | PPFIBP1 ANKRD26 AR CCDC88A PKP2 MACF1 GOLGA5 CDC25C UTRN AP3D1 GOLGA2 GOLGA4 GOLGB1 DNM2 | 7.03e-05 | 463 | 179 | 14 | int:LCK |
| Interaction | C3orf18 interactions | 7.58e-05 | 115 | 179 | 7 | int:C3orf18 | |
| Interaction | CCDC8 interactions | RANBP2 KRT14 MROH2A CUL9 CHD3 HUWE1 YWHAE ITPR2 CEP350 RND1 MDN1 ZBTB21 MACF1 PRKDC NUP188 UTRN GOLGB1 | 8.01e-05 | 656 | 179 | 17 | int:CCDC8 |
| Interaction | CEP95 interactions | 8.01e-05 | 50 | 179 | 5 | int:CEP95 | |
| Interaction | CAV1 interactions | PPFIBP1 ANXA3 PHB2 ANKRD26 PSMD12 SAR1A AR ACE2 CCDC88A RND1 PKP2 MACF1 GOLGA5 UTRN GOLGA2 CUX1 GOLGB1 MOV10 | 8.32e-05 | 724 | 179 | 18 | int:CAV1 |
| Interaction | SASS6 interactions | 8.98e-05 | 159 | 179 | 8 | int:SASS6 | |
| Interaction | AHI1 interactions | 9.67e-05 | 83 | 179 | 6 | int:AHI1 | |
| Interaction | TMOD1 interactions | 9.80e-05 | 161 | 179 | 8 | int:TMOD1 | |
| Interaction | TPTE2 interactions | 1.03e-04 | 84 | 179 | 6 | int:TPTE2 | |
| Interaction | DIRAS3 interactions | PPFIBP1 ANKRD26 FAM91A1 HUWE1 CCDC88A FEZ2 PIK3C3 PKP2 MACF1 GOLGA4 | 1.22e-04 | 262 | 179 | 10 | int:DIRAS3 |
| Interaction | DYNC1H1 interactions | NPHP1 FMR1 CUL9 HUWE1 LDHB YWHAE EXOSC2 AR SYNGAP1 ACE2 CCDC88A PRKDC RMC1 NIN | 1.31e-04 | 491 | 179 | 14 | int:DYNC1H1 |
| Interaction | RAC3 interactions | GIT1 PPFIBP1 ANKRD26 ADGRL1 FAM91A1 YWHAE AR CCDC88A PKP2 MACF1 ROCK1 GOLGA5 UTRN PLXNA1 GOLGA4 GOLGB1 | 1.35e-04 | 619 | 179 | 16 | int:RAC3 |
| Interaction | RCOR1 interactions | SOX6 RANBP2 HNF1B CHD3 HUWE1 AR KIF20B CCDC88A TET1 ZBTB21 GOLGA5 UTRN GOLGA2 CUX1 | 1.39e-04 | 494 | 179 | 14 | int:RCOR1 |
| Interaction | KXD1 interactions | 1.43e-04 | 170 | 179 | 8 | int:KXD1 | |
| Interaction | SHANK3 interactions | FMR1 GIT1 PHB2 ADGRL1 YWHAE SYNGAP1 ARFGEF3 PPP1R7 ACE2 KCNQ2 MACF1 KIF5A EXOC7 DNM2 | 1.45e-04 | 496 | 179 | 14 | int:SHANK3 |
| Interaction | SFN interactions | CCP110 SETD1A CRTC3 PPFIBP2 PPFIBP1 CCDC18 ANKRD26 YWHAE CEP350 HAUS8 CCDC88A IPO9 ZBTB21 PKP2 TJP2 MACF1 CDC25C | 1.52e-04 | 692 | 179 | 17 | int:SFN |
| Interaction | LATS1 interactions | CCP110 FXR2 CCDC18 ANKRD26 YWHAE MAP3K3 SPICE1 CEP350 CCDC88A MDN1 TJP2 GOLGA2 NIN | 1.61e-04 | 440 | 179 | 13 | int:LATS1 |
| Interaction | RHOJ interactions | GIT1 PPFIBP1 ANKRD26 ADGRL1 YWHAE ITGB5 ARFGEF3 CCDC88A MDN1 PKP2 MACF1 ROCK1 UTRN FMNL1 PLXNA1 GOLGA2 | 1.74e-04 | 633 | 179 | 16 | int:RHOJ |
| Interaction | RHOG interactions | GIT1 PPFIBP1 PHB2 ANKRD26 MRPS35 ADGRL1 FAM91A1 ELMO1 ARFGEF3 CCDC88A IPO9 PMPCA PRDX3 MACF1 ROCK1 GOLGA5 FMNL1 PLXNA1 GOLGA4 GOLGB1 | 1.77e-04 | 910 | 179 | 20 | int:RHOG |
| Interaction | CCDC66 interactions | 1.78e-04 | 32 | 179 | 4 | int:CCDC66 | |
| Interaction | HNF4A interactions | NCOA2 SETD1A ARID4B MED16 CHD3 AR PPARGC1B ZBTB21 SMARCD3 CUX1 | 1.81e-04 | 275 | 179 | 10 | int:HNF4A |
| Interaction | CHRM4 interactions | 1.93e-04 | 94 | 179 | 6 | int:CHRM4 | |
| Interaction | DLG4 interactions | FMR1 GIT1 PHB2 ADGRL1 HUWE1 YWHAE ELMO1 SYNGAP1 MACF1 KIF5A FRMPD3 GOLGA2 RASAL1 | 1.96e-04 | 449 | 179 | 13 | int:DLG4 |
| Interaction | EFTUD2 interactions | RANBP2 KRT14 ARHGAP24 GIT1 FXR2 RPP40 PPFIBP1 PHB2 MRPS35 CUL9 FAM91A1 EFHD2 CHD3 HUWE1 LDHB YWHAE EXOSC2 AR ACE2 PRDX3 SF3A3 MACF1 PRKDC AP3D1 GOLGA2 GOLGA4 GOLGB1 | 1.98e-04 | 1449 | 179 | 27 | int:EFTUD2 |
| Interaction | CRKL interactions | 2.02e-04 | 227 | 179 | 9 | int:CRKL | |
| Interaction | SCN2B interactions | 2.04e-04 | 95 | 179 | 6 | int:SCN2B | |
| Interaction | MTNR1B interactions | 2.07e-04 | 135 | 179 | 7 | int:MTNR1B | |
| Interaction | PIP interactions | 2.19e-04 | 181 | 179 | 8 | int:PIP | |
| Interaction | MAPRE3 interactions | 2.22e-04 | 230 | 179 | 9 | int:MAPRE3 | |
| Interaction | ISLR interactions | 2.36e-04 | 138 | 179 | 7 | int:ISLR | |
| Interaction | PRKD1 interactions | 2.45e-04 | 184 | 179 | 8 | int:PRKD1 | |
| Interaction | SLC15A3 interactions | 2.53e-04 | 234 | 179 | 9 | int:SLC15A3 | |
| Interaction | BAP1 interactions | RANBP2 HNF1B FXR2 MRPS35 EFHD2 PSMD12 HUWE1 IPO4 LDHB YWHAE EXOSC2 AR PPP1R7 PHKA1 IPO9 MDN1 PRDX3 SF3A3 MACF1 PRKDC EXOC7 AP3D1 GOLGA4 MOV10 DNM2 | 2.55e-04 | 1314 | 179 | 25 | int:BAP1 |
| Interaction | EPB41L4A interactions | 2.58e-04 | 140 | 179 | 7 | int:EPB41L4A | |
| Interaction | NCOA2 interactions | 2.70e-04 | 141 | 179 | 7 | int:NCOA2 | |
| Interaction | LATS2 interactions | 2.70e-04 | 289 | 179 | 10 | int:LATS2 | |
| Interaction | YWHAB interactions | CCP110 CRTC3 CENPE PPFIBP1 CCDC18 ANKRD26 LDHB YWHAE REEP2 MAP3K3 CEP350 ACE2 CCDC88A IPO9 PRDX3 ZBTB21 PKP2 TJP2 MACF1 KIF5A CDC25C | 2.72e-04 | 1014 | 179 | 21 | int:YWHAB |
| Interaction | KCNA3 interactions | NCOA2 ADCY10 RANBP2 PPFIBP1 LAMA1 PHB2 ANKRD26 PSMD12 YWHAE SPICE1 CCDC88A PKP2 MACF1 ROCK1 TRPM1 PRKDC AP3D1 GOLGA4 GOLGB1 | 2.84e-04 | 871 | 179 | 19 | int:KCNA3 |
| Interaction | OFD1 interactions | CCDC14 AHI1 CENPE CCDC18 SPICE1 CEP350 HAUS8 SLMAP UXT DNM2 NIN | 2.85e-04 | 347 | 179 | 11 | int:OFD1 |
| Interaction | KRT1 interactions | 2.86e-04 | 238 | 179 | 9 | int:KRT1 | |
| Interaction | SEMA5B interactions | 2.90e-04 | 15 | 179 | 3 | int:SEMA5B | |
| Interaction | KIF5B interactions | NCOA2 RANBP2 ARHGAP24 FMR1 PSMD12 HUWE1 YWHAE KIF5A RMC1 EXOC7 GOLGA4 | 2.92e-04 | 348 | 179 | 11 | int:KIF5B |
| Cytoband | 12p11 | 5.06e-06 | 9 | 182 | 3 | 12p11 | |
| GeneFamily | Exocyst complex | 2.39e-05 | 9 | 121 | 3 | 1055 | |
| GeneFamily | Plexins | 2.39e-05 | 9 | 121 | 3 | 683 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.51e-04 | 46 | 121 | 4 | 622 | |
| GeneFamily | UDP glucuronosyltransferases | 1.26e-03 | 32 | 121 | 3 | 363 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.93e-03 | 10 | 121 | 2 | 53 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.93e-03 | 10 | 121 | 2 | 830 | |
| GeneFamily | Maestro heat like repeat containing | 2.35e-03 | 11 | 121 | 2 | 636 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | NCOA2 RANBP2 AHI1 FMR1 ARID4B CENPE CCDC18 ANKRD26 KIF20B CCDC88A SLMAP ROCK1 PRKDC CUX1 GOLGA4 | 6.56e-08 | 311 | 179 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | NCOA2 HNF1B ARID4B CENPE TMEM69 CCDC18 HPSE2 KIF20B CCDC88A MACF1 ROCK1 TRPM1 GOLGB1 FILIP1L | 2.52e-07 | 298 | 179 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | NPHP1 HNF1B CRTC3 ARID4B CENPE TMEM69 CCDC18 HPSE2 GRIK4 LDHB ITGB5 KIF20B PHKA1 PIEZO2 CCDC88A EXOC6B MACF1 ROCK1 TRPM1 FMNL1 FILIP1L | 1.33e-06 | 744 | 179 | 21 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | AHI1 ARHGAP24 CENPE PPFIBP1 TMEM69 KIF20B SNX13 CEP350 SF3A3 ADAMTS20 DNAJC3 CUX1 GOLGA4 | 6.43e-06 | 339 | 179 | 13 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SOX6 CRTC3 KIF6 RIPOR2 MYO7A FXR2 PPFIBP2 PPFIBP1 LAMA1 ADGRL1 EFHD2 BCHE LDHB REEP2 ITGB5 ELMO1 FEZ2 SLMAP PADI2 PLXNA1 MOV10 | 1.76e-05 | 880 | 179 | 21 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | AHI1 CENPE PPFIBP2 CCDC18 ANKRD26 CHD3 KIF20B ITPR2 CLEC4F CCDC88A SLMAP MACF1 ROCK1 TRPM1 FILIP1L | 1.93e-05 | 492 | 179 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | NPHP1 ARHGAP24 CENPE PPFIBP2 CCDC18 ANKRD26 GRIK4 ITGB5 KIF20B ADCY8 ITPR2 PHKA1 PIEZO2 CCDC88A SLMAP MACF1 ROCK1 TRPM1 FMNL1 FILIP1L | 2.63e-05 | 834 | 179 | 20 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.95e-05 | 186 | 179 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | HNF1B ARID4B CENPE TMEM69 ACP3 CCDC18 HPSE2 KIF20B HAUS8 IPO9 TET1 SLMAP PKP2 TJP2 MACF1 ROCK1 TRPM1 FMNL1 GOLGB1 RASAL1 CCDC63 FILIP1L | 3.20e-05 | 989 | 179 | 22 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SOX6 MYO7A FXR2 PPFIBP2 PPFIBP1 ADGRL1 EFHD2 BCHE LDHB REEP2 ITGB5 ELMO1 MGAT5 SLMAP PLXNA4 PKP2 OS9 PADI2 PLXNA1 MOV10 | 5.94e-05 | 884 | 179 | 20 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | HNF1B CENPE ACP3 CCDC18 HPSE2 KIF20B TET1 PKP2 ROCK1 TRPM1 FMNL1 RASAL1 CCDC63 FILIP1L | 7.74e-05 | 492 | 179 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ARID4B CENPE TMEM69 CCDC18 KIF20B TET1 SLMAP MACF1 ROCK1 TRPM1 FMNL1 GOLGB1 FILIP1L | 8.03e-05 | 432 | 179 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | NCOA2 HNF1B CENPE ITFG2 PPFIBP2 ANKRD26 HPSE2 KIF20B SPICE1 LRIG2 HAUS8 CLEC4F CCDC88A IPO9 MACF1 ROCK1 UTRN PLXNA2 CCDC63 FILIP1L NIN | 8.94e-05 | 985 | 179 | 21 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | SOX6 RIPOR2 CENPE PPFIBP2 LAMA1 CCDC18 EFHD2 HPSE2 ISLR LDHB ITGB5 KIF20B SYNGAP1 ACE2 KRT24 PLXNA4 CDC25C MOV10 | 1.36e-04 | 793 | 179 | 18 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | NCOA2 CENPE ANKRD26 KIF20B CCDC88A MACF1 ROCK1 PLXNA2 FILIP1L NIN | 1.89e-04 | 291 | 179 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | NPHP1 CRTC3 ARHGAP24 FMR1 CENPE GRIK4 LDHB ITGB5 KIF20B PHKA1 EXOC6B MACF1 FMNL1 PLXNA2 FILIP1L | 2.03e-04 | 607 | 179 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.31e-04 | 192 | 179 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | NCOA2 HNF1B ARID4B CENPE TMEM69 CCDC18 HPSE2 LDHB YWHAE KIF20B CLEC4F CCDC88A MROH7 MACF1 ROCK1 TRPM1 GOLGB1 RASAL1 CCDC63 FILIP1L | 2.33e-04 | 979 | 179 | 20 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | HNF1B AHI1 ARHGAP24 MYO7A MROH2A ACP3 LAMA1 HUWE1 AR ACE2 ZBED4 ABCD4 PKP2 UGT2B15 UGT2B17 DNAJC3 CUX1 | 2.41e-04 | 758 | 179 | 17 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SOX6 NCOA2 RANBP2 AHI1 FMR1 ARID4B CENPE LAMA1 CCDC18 ANKRD26 GRIK4 REEP2 KIF20B CCDC88A SLMAP PKP2 ROCK1 PRKDC CUX1 GOLGA4 | 2.66e-04 | 989 | 179 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | CENPE PPFIBP2 ANKRD26 HPSE2 KIF20B HAUS8 IPO9 MACF1 ROCK1 UTRN PLXNA2 CCDC63 FILIP1L | 2.88e-04 | 492 | 179 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | SOX6 KRT14 RIPOR2 ARHGAP24 CENPE PPFIBP2 LAMA1 CCDC18 HPSE2 ISLR ITGB5 ACE2 PIEZO2 KRT24 TET1 PLXNA4 CUX1 | 3.21e-04 | 777 | 179 | 17 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | SOX6 MYO7A PPFIBP2 LAMA1 ADGRL1 EFHD2 BCHE LDHB REEP2 ELMO1 PADI2 MOV10 | 3.22e-04 | 433 | 179 | 12 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 3.25e-04 | 255 | 179 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 4.22e-04 | 210 | 179 | 8 | GSM403995_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | SOX6 CACNA1D KRT14 LAMA1 BCHE HPSE2 ISLR ITPR2 SYNGAP1 LRIG2 ACE2 CFAP54 KRT24 PRDX3 PLXNA4 PLXNA2 MOV10 | 4.30e-04 | 797 | 179 | 17 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | SOX6 HNF1B AHI1 ARHGAP24 CENPE PPFIBP1 TMEM69 LAMA1 KIF20B SNX13 CEP350 SF3A3 PKP2 ADAMTS20 DNAJC3 CUX1 GOLGA4 | 4.55e-04 | 801 | 179 | 17 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | CCDC14 NPHP1 CCP110 AHI1 AZU1 CCDC18 KIF20B CEP350 ZBTB21 UTRN | 7.91e-09 | 194 | 182 | 10 | dff3fb10372053951d41e0ccd41aac3ece6009bd |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | CCDC18 ANKRD26 PSMD12 KIF20B CEP350 CCDC88A ROCK1 UTRN GOLGA4 GOLGB1 | 9.62e-09 | 198 | 182 | 10 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.02e-07 | 192 | 182 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 193 | 182 | 9 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | ARID4B ANKRD26 PSMD12 CEP350 ROCK1 DNAJC3 AP3D1 GOLGA4 GOLGB1 | 1.38e-07 | 199 | 182 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-07 | 181 | 182 | 8 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.36e-07 | 184 | 182 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.36e-07 | 184 | 182 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.36e-07 | 184 | 182 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.75e-07 | 185 | 182 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-06 | 186 | 182 | 8 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 193 | 182 | 8 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 193 | 182 | 8 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 193 | 182 | 8 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.50e-06 | 196 | 182 | 8 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.66e-06 | 88 | 182 | 6 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.66e-06 | 88 | 182 | 6 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.66e-06 | 88 | 182 | 6 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-06 | 165 | 182 | 7 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.03e-06 | 168 | 182 | 7 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-06 | 169 | 182 | 7 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.03e-06 | 172 | 182 | 7 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.03e-06 | 172 | 182 | 7 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.87e-06 | 175 | 182 | 7 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 9.46e-06 | 180 | 182 | 7 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.46e-06 | 180 | 182 | 7 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-06 | 181 | 182 | 7 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 1.05e-05 | 183 | 182 | 7 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.05e-05 | 183 | 182 | 7 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.09e-05 | 184 | 182 | 7 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 187 | 182 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 187 | 182 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.25e-05 | 188 | 182 | 7 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.25e-05 | 188 | 182 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-05 | 190 | 182 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-05 | 191 | 182 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.44e-05 | 192 | 182 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-05 | 194 | 182 | 7 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-05 | 194 | 182 | 7 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.54e-05 | 194 | 182 | 7 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 195 | 182 | 7 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 195 | 182 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.59e-05 | 195 | 182 | 7 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.64e-05 | 196 | 182 | 7 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-05 | 196 | 182 | 7 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-05 | 196 | 182 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.64e-05 | 196 | 182 | 7 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-05 | 196 | 182 | 7 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 197 | 182 | 7 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.70e-05 | 197 | 182 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.81e-05 | 199 | 182 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 199 | 182 | 7 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.81e-05 | 199 | 182 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.81e-05 | 199 | 182 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.81e-05 | 199 | 182 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.81e-05 | 199 | 182 | 7 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | Biopsy_IPF-Immune-cDCs|Biopsy_IPF / Sample group, Lineage and Cell type | 1.87e-05 | 200 | 182 | 7 | f7730e2d3ed14a86141491fd20e3aa562670c757 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.87e-05 | 200 | 182 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-05 | 200 | 182 | 7 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.42e-05 | 140 | 182 | 6 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-05 | 159 | 182 | 6 | 6e2d38e78d2ef7803e8bb154b5c788bf62a41045 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-05 | 159 | 182 | 6 | f7803f7b4e0379ae8256ec53110833bedee7db98 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 162 | 182 | 6 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 164 | 182 | 6 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 164 | 182 | 6 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 164 | 182 | 6 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 5.86e-05 | 164 | 182 | 6 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 6.06e-05 | 165 | 182 | 6 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 165 | 182 | 6 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.06e-05 | 165 | 182 | 6 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.06e-05 | 165 | 182 | 6 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 165 | 182 | 6 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-05 | 168 | 182 | 6 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.92e-05 | 169 | 182 | 6 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.92e-05 | 169 | 182 | 6 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-05 | 170 | 182 | 6 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.12e-05 | 174 | 182 | 6 | c2f8c59fca5f1ff6ffa6dc8cfce62da4b19fe9b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-05 | 174 | 182 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.12e-05 | 174 | 182 | 6 | 0227fea1678baa9168bd47c3b4aacb2592bb5867 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 8.12e-05 | 174 | 182 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.12e-05 | 174 | 182 | 6 | 84024c04b0ce9f7068677d2d99ede56882b7dbd2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-05 | 175 | 182 | 6 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-05 | 175 | 182 | 6 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.38e-05 | 175 | 182 | 6 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.93e-05 | 177 | 182 | 6 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.21e-05 | 178 | 182 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.49e-05 | 179 | 182 | 6 | af03705a783e77f75c44fdfa793cfdccbf9dd91c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-05 | 179 | 182 | 6 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | Control|World / 5 Neutrophil clusters in COVID-19 patients | 9.69e-05 | 112 | 182 | 5 | b3e5a901f3dbd6e49e968dd2a371f68274951735 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-05 | 180 | 182 | 6 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | 15-Airway-Epithelial-Submucosal_gland|Airway / Age, Tissue, Lineage and Cell class | 9.79e-05 | 180 | 182 | 6 | 283bb0d58811947bfda4e286b9ec87d869c8e29e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.79e-05 | 180 | 182 | 6 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-05 | 180 | 182 | 6 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-05 | 180 | 182 | 6 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 181 | 182 | 6 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.01e-04 | 113 | 182 | 5 | dc002185095590fc071b2f39259f8b87a757e174 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 182 | 182 | 6 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 182 | 182 | 6 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 182 | 182 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 182 | 182 | 6 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.29e-06 | 49 | 109 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.44e-04 | 50 | 109 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | NCOA2 ITFG2 ANXA3 ANKRD26 TUBGCP2 CCDC88A PRDX3 SLC24A1 UTRN GOLGA2 | 3.66e-06 | 194 | 181 | 10 | 1310_DN |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A | FXR2 MED16 ANKRD26 CHD3 PPP1R7 ZBED4 PRDX3 EXOC6B UTRN GOLGA2 | 4.39e-06 | 198 | 181 | 10 | 5799_DN |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | CACNA1D AHI1 ITFG2 FXR2 ADGRL1 EFHD2 ITGB5 AP5Z1 PRDX3 RHBDD3 | 4.39e-06 | 198 | 181 | 10 | 5242_DN |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.62e-05 | 194 | 181 | 9 | 3280_DN | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.73e-05 | 195 | 181 | 9 | 1501_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | CACNA1D PPFIBP1 SLC12A8 AP5Z1 CD34 EXOC7 GRAMD1C UTRN FILIP1L | 2.73e-05 | 195 | 181 | 9 | 4980_DN |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.73e-05 | 195 | 181 | 9 | 4393_DN | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 2.73e-05 | 195 | 181 | 9 | 3452_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.84e-05 | 196 | 181 | 9 | 3763_UP | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.84e-05 | 196 | 181 | 9 | 5636_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 4160_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 2837_DN | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 2822_DN | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | PPFIBP1 ANKRD26 ADGRL1 ITGB5 KIF20B SNX13 ITPR2 NUP188 EXOC7 | 2.96e-05 | 197 | 181 | 9 | 2860_DN |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 1640_DN | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 2853_DN | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.07e-05 | 198 | 181 | 9 | 6976_UP | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 3.07e-05 | 198 | 181 | 9 | 5399_UP | |
| Drug | ST021200; Down 200; 10uM; MCF7; HT_HG-U133A | ITFG2 PPFIBP1 ACP3 SLC12A8 CHD3 PPP1R7 SMARCD3 DNAJC3 FILIP1L | 3.07e-05 | 198 | 181 | 9 | 7488_DN |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.07e-05 | 198 | 181 | 9 | 7433_UP | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; HL60; HT_HG-U133A | SETD1A CENPE SLC12A8 EXOSC2 ITPR2 SMARCD3 NUP188 CDC25C PADI2 | 3.20e-05 | 199 | 181 | 9 | 2706_DN |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; PC3; HT_HG-U133A | NCOA2 AHI1 ITFG2 SNX13 CCDC88A ABCD4 SMARCD3 GRAMD1C FILIP1L | 3.33e-05 | 200 | 181 | 9 | 4639_DN |
| Drug | 4-phenylphenol | 4.01e-05 | 9 | 181 | 3 | ctd:C019046 | |
| Drug | fluorochrome | 4.29e-05 | 80 | 181 | 6 | CID000008505 | |
| Drug | Cyclopentanes | 6.29e-05 | 2 | 181 | 2 | ctd:D003517 | |
| Drug | Equol | 6.93e-05 | 54 | 181 | 5 | ctd:D060754 | |
| Drug | AC1MO44G | 9.40e-05 | 92 | 181 | 6 | CID003363161 | |
| Drug | coelenteramide | 1.17e-04 | 32 | 181 | 4 | CID005326781 | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.30e-04 | 187 | 181 | 8 | 2571_UP | |
| Drug | AC1L1HQG | 1.44e-04 | 142 | 181 | 7 | CID000004246 | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 191 | 181 | 8 | 3975_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.56e-04 | 192 | 181 | 8 | 4144_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; HL60; HG-U133A | 1.56e-04 | 192 | 181 | 8 | 1419_DN | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 1.62e-04 | 193 | 181 | 8 | 7490_UP | |
| Drug | AC1NOWCJ | 1.67e-04 | 35 | 181 | 4 | CID005120112 | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.67e-04 | 194 | 181 | 8 | 1219_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.67e-04 | 194 | 181 | 8 | 3100_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 195 | 181 | 8 | 2624_UP | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.73e-04 | 195 | 181 | 8 | 2707_DN | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.73e-04 | 195 | 181 | 8 | 3246_UP | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; HL60; HT_HG-U133A | 1.73e-04 | 195 | 181 | 8 | 2358_DN | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 195 | 181 | 8 | 7361_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.80e-04 | 196 | 181 | 8 | 5279_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; HL60; HT_HG-U133A | 1.80e-04 | 196 | 181 | 8 | 2999_UP | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.80e-04 | 196 | 181 | 8 | 2844_DN | |
| Drug | Gleevec; Up 200; 10uM; PC3; HG-U133A | 1.80e-04 | 196 | 181 | 8 | 483_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.80e-04 | 196 | 181 | 8 | 7183_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 197 | 181 | 8 | 5340_DN | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 1.86e-04 | 197 | 181 | 8 | 7510_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.86e-04 | 197 | 181 | 8 | 1017_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 197 | 181 | 8 | 6237_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 197 | 181 | 8 | 7185_DN | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 1.86e-04 | 197 | 181 | 8 | 1314_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.86e-04 | 197 | 181 | 8 | 5411_UP | |
| Drug | IL-w | 1.88e-04 | 3 | 181 | 2 | CID006439489 | |
| Drug | 4-androstene-3,17-diol | 1.88e-04 | 3 | 181 | 2 | ctd:C021287 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 5904_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 4971_DN | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 7327_UP | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 6302_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 5479_UP | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 2786_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 4414_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 3748_UP | |
| Drug | Triflusal [322-79-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 7451_UP | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 4976_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 5524_UP | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 4131_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 2348_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 2622_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 5335_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.92e-04 | 198 | 181 | 8 | 3609_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; HL60; HG-U133A | 1.92e-04 | 198 | 181 | 8 | 1756_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 5788_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 4334_UP | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; HL60; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 1847_UP | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 5415_UP | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 2883_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 4295_UP | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; MCF7; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 6511_UP | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 4206_UP | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 1.99e-04 | 199 | 181 | 8 | 6072_UP | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; PC3; HT_HG-U133A | 2.06e-04 | 200 | 181 | 8 | 6690_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A | 2.06e-04 | 200 | 181 | 8 | 2905_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; PC3; HT_HG-U133A | 2.06e-04 | 200 | 181 | 8 | 4006_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 200 | 181 | 8 | 3276_DN | |
| Disease | urofacial syndrome (is_implicated_in) | 3.58e-05 | 2 | 177 | 2 | DOID:0050816 (is_implicated_in) | |
| Disease | Ochoa syndrome | 3.58e-05 | 2 | 177 | 2 | C0403555 | |
| Disease | Mixed anxiety and depressive disorder | 3.58e-05 | 2 | 177 | 2 | C0338908 | |
| Disease | Prostatic Neoplasms | NCOA2 HNF1B PPFIBP2 ANXA3 CHD3 LDHB AR UGT2B15 UGT2B17 PRKDC UXT DNAJC3 GOLGA4 | 9.52e-05 | 616 | 177 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | NCOA2 HNF1B PPFIBP2 ANXA3 CHD3 LDHB AR UGT2B15 UGT2B17 PRKDC UXT DNAJC3 GOLGA4 | 9.52e-05 | 616 | 177 | 13 | C0376358 |
| Disease | fragile X syndrome (implicated_via_orthology) | 1.07e-04 | 3 | 177 | 2 | DOID:14261 (implicated_via_orthology) | |
| Disease | cholic acid glucuronide measurement | 1.07e-04 | 3 | 177 | 2 | EFO_0800574 | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 1.07e-04 | 3 | 177 | 2 | DOID:7474 (implicated_via_orthology) | |
| Disease | Joubert syndrome 4 (is_implicated_in) | 1.07e-04 | 3 | 177 | 2 | DOID:0110999 (is_implicated_in) | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.78e-04 | 194 | 177 | 7 | EFO_0004265, EFO_0007908 | |
| Disease | X-25937 measurement | 2.13e-04 | 4 | 177 | 2 | EFO_0800937 | |
| Disease | t-cell surface glycoprotein CD8 beta chain measurement | 2.13e-04 | 4 | 177 | 2 | EFO_0803135 | |
| Disease | trypanosomiasis (biomarker_via_orthology) | 2.13e-04 | 4 | 177 | 2 | DOID:10113 (biomarker_via_orthology) | |
| Disease | integrin alpha-5 measurement | 2.13e-04 | 4 | 177 | 2 | EFO_0802637 | |
| Disease | protocadherin beta-1 measurement | 2.13e-04 | 4 | 177 | 2 | EFO_0802972 | |
| Disease | histone acetyltransferase type b catalytic subunit measurement | 2.13e-04 | 4 | 177 | 2 | EFO_0020452 | |
| Disease | cup-to-disc ratio measurement | KIF6 PSMD12 ADCY8 RGL1 CROCC2 TET1 CHSY3 PLXNA1 CUX1 FILIP1L | 2.88e-04 | 430 | 177 | 10 | EFO_0006939 |
| Disease | C-type lectin domain family 4 member D measurement | 3.54e-04 | 5 | 177 | 2 | EFO_0802347 | |
| Disease | adenylyltransferase and sulfurtransferase MOCS3 measurement | 3.54e-04 | 5 | 177 | 2 | EFO_0802257 | |
| Disease | augurin measurement | 3.54e-04 | 5 | 177 | 2 | EFO_0801399 | |
| Disease | uncharacterized protein C3orf18 measurement | 3.54e-04 | 5 | 177 | 2 | EFO_0802193 | |
| Disease | Intellectual Disability | 3.91e-04 | 447 | 177 | 10 | C3714756 | |
| Disease | v-set and transmembrane domain-containing protein 4 measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0803247 | |
| Disease | peptidyl-prolyl cis-trans isomerase-like 2 measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0801877 | |
| Disease | Headache | 6.01e-04 | 64 | 177 | 4 | HP_0002315 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 6.61e-04 | 115 | 177 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | baculoviral IAP repeat-containing protein 5 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0020174 | |
| Disease | C-C motif chemokine 1 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0008041 | |
| Disease | uroplakin-3b-like protein measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0802204 | |
| Disease | X-24574 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0800897 | |
| Disease | glutathione S-transferase A4 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0801637 | |
| Disease | MASA syndrome (implicated_via_orthology) | 7.37e-04 | 7 | 177 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | central nervous system cancer | 8.43e-04 | 31 | 177 | 3 | EFO_0000326 | |
| Disease | Hyperkinesia | 9.26e-04 | 32 | 177 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 9.26e-04 | 32 | 177 | 3 | C0751217 | |
| Disease | Schizophrenia | SETD1A AHI1 FMR1 LAMA1 GRIK4 YWHAE SYNGAP1 PIK3C3 TET1 KCNQ2 TRPM1 CDC25C IL4 PLXNA2 | 9.30e-04 | 883 | 177 | 14 | C0036341 |
| Disease | tumor necrosis factor receptor superfamily member 3 measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0020813 | |
| Disease | desmoglein-1 measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0020321 | |
| Disease | protein sel-1 homolog 2 measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0801962 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0801373 | |
| Disease | deoxycholic acid glucuronide measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0800575 | |
| Disease | chromobox protein homolog 5 measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0020258 | |
| Disease | kallikrein-6 measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0801739 | |
| Disease | basal cell carcinoma | 1.01e-03 | 189 | 177 | 6 | EFO_0004193 | |
| Disease | nephronophthisis (implicated_via_orthology) | 1.25e-03 | 9 | 177 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | epididymal-specific lipocalin-10 measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0801576 | |
| Disease | cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0020296 | |
| Disease | endothelin-converting enzyme 1 measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0008121 | |
| Disease | mast cell-expressed membrane protein 1 measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0801787 | |
| Disease | interleukin-34 measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0020505 | |
| Disease | cortical surface area measurement | NCOA2 EXOC6 KIF6 PPFIBP1 CUL9 SLC12A8 ITGB5 KIF20B SNX13 CCDC88A PMPCA EXOC6B ADAMTS20 MACF1 CDC25C PLXNA2 CUX1 MOV10 | 1.26e-03 | 1345 | 177 | 18 | EFO_0010736 |
| Disease | tropomyosin beta chain measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0020787 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0022090 | |
| Disease | axin-2 measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0801400 | |
| Disease | interleukin-37 measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0020506 | |
| Disease | insulin growth factor-like family member 3 measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0801700 | |
| Disease | stromal interaction molecule 1 measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0802093 | |
| Disease | Disorder of eye | 1.82e-03 | 212 | 177 | 6 | C0015397 | |
| Disease | PR domain zinc finger protein 1 measurement | 1.90e-03 | 11 | 177 | 2 | EFO_0801904 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.90e-03 | 11 | 177 | 2 | EFO_0801531 | |
| Disease | interleukin-10 receptor subunit alpha measurement | 1.90e-03 | 11 | 177 | 2 | EFO_0021890 | |
| Disease | Night blindness, congenital stationary, type 1 | 2.27e-03 | 12 | 177 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 2.27e-03 | 12 | 177 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 2.27e-03 | 12 | 177 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 2.27e-03 | 12 | 177 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 2.27e-03 | 12 | 177 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 2.27e-03 | 12 | 177 | 2 | C1848172 | |
| Disease | oncostatin-M measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0010792 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0800291 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0020833 | |
| Disease | phosphocreatine measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0010521 | |
| Disease | kallikrein-12 measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0008194 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 2.67e-03 | 13 | 177 | 2 | C4041558 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 2.67e-03 | 13 | 177 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0800293 | |
| Disease | X-19141 measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0800799 | |
| Disease | cortical thickness | NCOA2 KIF6 RIPOR2 PPFIBP1 LAMA1 MRPS35 CUL9 SLC12A8 ITGB5 KIF20B CCDC88A PMPCA ADAMTS20 MACF1 PLXNA2 | 3.00e-03 | 1113 | 177 | 15 | EFO_0004840 |
| Disease | Pneumoconiosis | 3.11e-03 | 14 | 177 | 2 | C0032273 | |
| Disease | Bagassosis | 3.11e-03 | 14 | 177 | 2 | C0004681 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 3.11e-03 | 14 | 177 | 2 | EFO_0800283 | |
| Disease | vital capacity | SOX6 AHI1 TCP11 TMEM74 PCDHA13 ADCY8 SNX13 CROCC2 SLMAP CHSY3 MYO18B RMC1 UTRN PLXNA1 MOV10 FILIP1L | 3.26e-03 | 1236 | 177 | 16 | EFO_0004312 |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 3.38e-03 | 50 | 177 | 3 | EFO_0010732 | |
| Disease | Sinus Node Dysfunction (disorder) | 3.57e-03 | 15 | 177 | 2 | C0428908 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.79e-03 | 171 | 177 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | urate measurement, bone density | KIF6 ARHGAP24 PPFIBP1 ITPR2 PPP1R7 CD34 PLXNA4 PRKDC UTRN RASAL1 | 4.34e-03 | 619 | 177 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Inborn Errors of Metabolism | 4.59e-03 | 17 | 177 | 2 | C0025521 | |
| Disease | esophageal carcinoma, gastric carcinoma | 4.59e-03 | 17 | 177 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | Night blindness, congenital stationary | 4.59e-03 | 17 | 177 | 2 | C0339535 | |
| Disease | bone fracture | 4.70e-03 | 112 | 177 | 4 | EFO_0003931 | |
| Disease | migraine disorder, systolic blood pressure | 5.14e-03 | 18 | 177 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 5.14e-03 | 18 | 177 | 2 | EFO_0800288 | |
| Disease | Malignant neoplasm of breast | NCOA2 TRIML1 KIF6 KRT14 BCHE LDHB AR EPG5 RGL1 PPARGC1B MROH7 MACF1 CUX1 GOLGB1 | 5.48e-03 | 1074 | 177 | 14 | C0006142 |
| Disease | prostate cancer (is_implicated_in) | 5.48e-03 | 117 | 177 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | keratinocyte carcinoma | 5.65e-03 | 118 | 177 | 4 | EFO_0010176 | |
| Disease | cotinine glucuronidation measurement | 5.72e-03 | 19 | 177 | 2 | EFO_0006508 | |
| Disease | age at onset, smoking initiation | 5.72e-03 | 19 | 177 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | etiocholanolone glucuronide measurement | 5.72e-03 | 19 | 177 | 2 | EFO_0800362 | |
| Disease | asthma | AHI1 ARID4B TCP11 TLR10 HAUS8 KRT24 MGAT5 LRRC37A5P PIK3C3 MROH7 IL4 | 5.84e-03 | 751 | 177 | 11 | MONDO_0004979 |
| Disease | total blood protein measurement | 5.91e-03 | 449 | 177 | 8 | EFO_0004536 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSTLIMQLLRDNLTL | 216 | P62258 | |
| LSTTLSAQELVRMLN | 426 | P40145 | |
| TVSSDQMAKLRSLLS | 216 | P07451 | |
| NMTSAERITILQEKL | 1226 | Q4LE39 | |
| SDILRLLMQSSAEQL | 1831 | Q9HCE0 | |
| LNTESTRIMTKLRAQ | 531 | P06276 | |
| VLRDSIVMLEQLKSS | 626 | Q8IYS0 | |
| ELRQLELMSSSKSQE | 326 | Q96N23 | |
| VSTLMLNKSILEDLD | 481 | Q8NHU2 | |
| LTRNDLDTLLSMEIK | 681 | Q92556 | |
| ARNARSLLSMLKDIS | 31 | Q96LI9 | |
| SSSTKMQLVKQRLET | 971 | Q8N157 | |
| ERKLQETQMSTTSKL | 176 | P39880 | |
| SSSVKLMEQLLDILD | 571 | O94910 | |
| QQLKSRILMTATQES | 1691 | Q7Z2Y8 | |
| TDEKMLISILTERSN | 36 | P12429 | |
| LTALTDENTMLRSKL | 86 | Q96IX9 | |
| QQLMKVNSSLSDELR | 441 | Q9Y2X7 | |
| LMTTLTKLASRSQDL | 701 | O43299 | |
| QLRETLLDMSLKSQD | 346 | O14678 | |
| LKEISLIQLDSMRLS | 811 | Q96PN6 | |
| SLQTLEMELRTVKSN | 836 | Q9UPS8 | |
| LRELTRTLQTSMAKL | 636 | Q49A88 | |
| RTLQTSMAKLLSDLS | 641 | Q49A88 | |
| SQLIKSDEMQRLRSQ | 146 | Q13217 | |
| RIDLTSMQIKTTDLL | 1806 | P59510 | |
| STLLSNLLEEMKATL | 1136 | O14617 | |
| LDSLSSSVRKQAMEI | 471 | Q68CQ1 | |
| SSVRKQAMEILTQLS | 476 | Q68CQ1 | |
| RLKLLEDSNMDTTLE | 741 | O95294 | |
| NLMLLTLSTRDVQES | 241 | P49792 | |
| MEEQVKLRSRTSLTL | 736 | Q9NZL6 | |
| IRSLQEKLESTMSLV | 2646 | Q14571 | |
| TSQARDLLSKMLVID | 291 | P45984 | |
| RSENLNLSIKMDLTR | 1251 | Q14667 | |
| QQSTTRLTEMLKTIK | 4381 | Q9NU22 | |
| LLMSLVQTTDRNKEL | 326 | Q4G0Z9 | |
| ILETNSLKRIMEETT | 231 | O60721 | |
| SLRTKLLLMSRNEEA | 201 | P51116 | |
| ESSSMLREQILDLSK | 41 | Q09328 | |
| KLLSEQQELRTVSMT | 76 | Q49AS3 | |
| SRTSLETQKLDLMAE | 161 | Q86W92 | |
| LETELKSQTARIMEL | 1516 | Q13439 | |
| LEIELQSQLSMKASL | 341 | P02533 | |
| LNQEMASLLQRSKET | 241 | Q8TBA6 | |
| TSLNSSILAALRKMQ | 576 | P46020 | |
| VTMLNASSQLADRKL | 656 | Q658Y4 | |
| ELTSSRLLKLEMENQ | 456 | Q3V6T2 | |
| LSALQLLKMDSNELT | 121 | O14498 | |
| LRSKLEQVVDTMALS | 1881 | Q9UIW2 | |
| LLRRTESVAEKMLTN | 1426 | O75051 | |
| LLRRTESVAEKMLTN | 1426 | Q9HCM2 | |
| MRDLTASNKVSLALL | 371 | Q9HB15 | |
| LDMLSRIKSLQSRVD | 576 | O43526 | |
| ETLKLSMSLQVLRLS | 416 | Q6UY01 | |
| IMKLSNEIETATRSI | 961 | Q96Q89 | |
| TTMIATLSLEKRNLD | 316 | Q6ZMV9 | |
| LEIELQSQLAMKSSL | 371 | Q2M2I5 | |
| IARELSKMAQLTELS | 271 | A6NHZ5 | |
| TGSTLQQSLELKRKM | 146 | Q9BSJ2 | |
| LKDILSEASTMQLLQ | 181 | P10275 | |
| EVDDMIRKSTNLLLT | 521 | Q9Y2D4 | |
| TLLSLEKQTRTASDM | 46 | O00232 | |
| MSSKRITINKILSNE | 521 | Q9Y2J8 | |
| MDFLKTRLLDTLSDQ | 346 | Q8WWQ2 | |
| DQKTQRLLSREISSM | 111 | Q8IY84 | |
| IKDMILQFISRESSL | 156 | P50570 | |
| NSRLDSVLLLSSMNL | 101 | Q13868 | |
| KLEMTELLLQQFSSR | 341 | Q08379 | |
| SQTLLLTLLSVKMEN | 151 | Q9BT25 | |
| AELKSTRMILNLTQS | 1796 | Q7Z6Z7 | |
| LSLSMKDDLDNIRSL | 146 | P18084 | |
| SKDLQMVNISLRVLS | 96 | Q99623 | |
| TEIDDMLRKSTNLLL | 511 | Q8TAG9 | |
| MLRKSTNLLLTRTLS | 516 | Q8TAG9 | |
| LERMESTNLVKLLET | 386 | Q969R8 | |
| LSSFESRLMKLENSI | 46 | Q9UPT5 | |
| SRTSLETQKLDLMTE | 166 | Q8ND30 | |
| VQLESSLLRSKAMLN | 4941 | Q9UPN3 | |
| RKMLNLLLERDTSFT | 26 | P30307 | |
| DTQDSMSLLFRLLTK | 681 | Q9Y2X0 | |
| LEQMSSLSLVLRKTL | 186 | Q9Y5I0 | |
| MLVVLQELRDSNSSK | 1 | Q8NGI1 | |
| TMTKLRELSELSLLS | 231 | P15309 | |
| NLMLLTLSTRDVQES | 241 | A6NKT7 | |
| IKSLEQRNLTLETEM | 666 | Q8N264 | |
| SLRTKLSLIMRNEEA | 191 | Q06787 | |
| STLENFLERLKTIMR | 131 | P05112 | |
| DEITLLLSLMKSSRN | 71 | Q8NA47 | |
| LSQLDMILDQTKTEL | 901 | Q5T9S5 | |
| LLFLSRSISMKQNVE | 131 | Q6ZN84 | |
| MQQALSLKETERSLL | 941 | H7BZ55 | |
| ERMTTKQLSQELESL | 451 | Q4L180 | |
| LQMSERSILSRLASK | 1896 | Q12873 | |
| LMTDLTLSRVQFQKL | 36 | Q6UUV7 | |
| TVKDVMLTLQDRLSL | 201 | Q5JV73 | |
| ATLSQMLSDLTLQLR | 161 | Q5TH69 | |
| LLKELNATSRILDMS | 2231 | Q5VT06 | |
| LEMLEKILQRQFSSS | 351 | Q96C10 | |
| DKSKRLNTILNTMST | 111 | Q9BYF1 | |
| RKISDSSLLETMLSQ | 716 | O43303 | |
| DLEQMRTKLSSLATA | 611 | Q8TF76 | |
| QKDQMLLDTLTRSLD | 161 | P43080 | |
| VLKNDMKSRLSSLSL | 1556 | Q9Y4F3 | |
| LNQEVTSKDMLRTLA | 91 | Q9BV29 | |
| LQSLDALLEMKSTDR | 861 | O95466 | |
| LRAILSKMQQAETLS | 786 | Q96P70 | |
| QKVATMLSLESELQR | 521 | Q12840 | |
| SVADLIESMLKNLSR | 256 | P07195 | |
| QLMLQSLSTSEELQR | 1631 | Q8IWT3 | |
| MATDELATKLSRRLQ | 1 | Q96C19 | |
| DRKISLIMELSTQVS | 216 | P0DO97 | |
| QFLISKDTLSVRMLD | 181 | Q16099 | |
| LMLLQLDREANLTSS | 116 | P20160 | |
| NLTVLSMQSNRLTKI | 231 | Q15435 | |
| DMDQLLQLTRKLESS | 461 | A0AV02 | |
| LLTEDMQALTLRTLA | 31 | Q52WX2 | |
| EQITTLMLLSLRSTE | 606 | Q8TEX9 | |
| LSNLVASLLNSMKSI | 636 | Q01668 | |
| NEKIENLTRMLVTSS | 391 | Q02224 | |
| SIESKMLELTNRLQE | 1566 | Q02224 | |
| VLANRTEISSKLQLM | 246 | P28906 | |
| VLLKDRMSLQSTDLI | 591 | O15259 | |
| LSMLSQEIQTLKRSS | 191 | Q9UHY8 | |
| SSMKSLRILLLSQDR | 111 | Q99759 | |
| ALSSLEQLMESLLQR | 926 | A6NES4 | |
| VSIDLMELSLNLDSK | 146 | O75818 | |
| MVSKLTSLQQELLSA | 1 | P35680 | |
| SSSERNILETLLQMK | 256 | P82673 | |
| TVELERAKTQLTSML | 421 | Q10713 | |
| MRITEQFESLSSILK | 621 | Q9Y5W8 | |
| SSLKNMKEIETNLRS | 1071 | P46939 | |
| NLMLLTLSTRDVQES | 241 | Q7Z3J3 | |
| LLLTKMDIENLTISN | 321 | Q9BXR5 | |
| TSLVLTQEREMLEKT | 886 | Q8N4C6 | |
| ELDRVKLSFSMSLLS | 421 | Q9HCE1 | |
| KTDLRTDLSTLMELS | 126 | Q92730 | |
| TDNLQKKLTRMLAST | 1626 | P25391 | |
| TLSEDQMSRLAKLTK | 166 | Q8NEB9 | |
| IQNLSSDMSSRELKR | 906 | Q86YN6 | |
| QDLLRSQSRDLKVMT | 421 | Q6STE5 | |
| TSRTDILSLKMSLQQ | 26 | Q5SWH9 | |
| MVSKLSQLTSLLSSI | 261 | Q92835 | |
| SRLVESKVELNALMT | 106 | Q9NR31 | |
| MNIALLSDLTKQISR | 156 | P30048 | |
| MLENLLSQRKTISVE | 81 | Q8NH09 | |
| SSLDSRIEMLLKEQR | 486 | O15047 | |
| RDRAMLALTSTLNKL | 486 | Q13438 | |
| SMVQTLQSLRDEKLL | 911 | Q9Y4F9 | |
| LQSLRDEKLLQTMSD | 916 | Q9Y4F9 | |
| KDIMTRIADLTLQNS | 666 | Q8N0Z3 | |
| EKERQLSTMITQLIS | 186 | P35712 | |
| SLLSLMKDRRLTLEQ | 876 | Q8NFU7 | |
| SLQRQSLLDMSLVKL | 31 | Q9BXL8 | |
| TIQLHRESALMSKLS | 421 | Q70JA7 | |
| LKDATTLSLQTQMLR | 156 | Q8N1N0 | |
| LLQLLTTKSDQMEPS | 641 | Q15596 | |
| KSSVSSLRLQQLERM | 321 | Q9Y3P4 | |
| KSVLQIEQLQSMRSS | 111 | Q495C1 | |
| EMKTSQESLLRSRLS | 216 | Q5VZI3 | |
| ETLLMDRTRLQELKS | 311 | Q8WWU5 | |
| RLNQVTADTLTLTMK | 411 | Q6NUS8 | |
| VKSLLRRSLSMDSQV | 336 | Q9ULJ3 | |
| TVTENMSLTDARKLI | 356 | Q9UDY2 | |
| VLSEKLRSFSMQDLT | 141 | Q9BRK0 | |
| LLTELSNSLTKDSMN | 116 | Q9UBK9 | |
| DTMRNLLSTQKDAIL | 491 | Q9ULX5 | |
| RRLLSQEEQTSKILM | 1221 | Q96PV0 | |
| SRTSLTLNQKLEMIK | 11 | Q96MW7 | |
| SLDMLKRLSTANDEI | 551 | Q96DM3 | |
| SMKASLQTVDIRLAQ | 1266 | Q9HCF6 | |
| SLELTSDLSILQMSR | 701 | Q14BN4 | |
| SDLSILQMSRKELEN | 706 | Q14BN4 | |
| FMDITIILSRDNTTK | 2611 | Q9H5I5 | |
| LLTTLEVSLRMKQNL | 1316 | Q5SRE5 | |
| QRMKQELSSELSTLL | 1681 | Q5SRE5 | |
| ITAAQLQTMLLEKSR | 731 | Q8IUG5 | |
| LENTVTLKDLLLNTM | 3806 | P78527 | |
| MSKSISQLESLNREL | 571 | Q13464 | |
| MKTSLQTVDLRLAQL | 1206 | Q7Z4N2 | |
| QIRSLSKMIAQIESS | 221 | Q8N9V2 | |
| MLTKKSTLRDQINSD | 26 | Q12874 | |
| MSSRDLLNALKSVIN | 421 | P54855 | |
| RMKTSTNENTLELSL | 281 | Q96NL1 | |
| KIASDLTRSQDLMIN | 106 | Q9NZL3 | |
| KNLMITEALLTLTEN | 516 | Q99959 | |
| MSSRDLLNALKSVIN | 421 | O75795 | |
| KQDLIRELELMNSTS | 1026 | O75132 | |
| RDQLLSQVKELSMVT | 746 | Q14789 | |
| TLLSSNASMKEELER | 1716 | Q14789 | |
| SSSLLVVKLNRNRMS | 191 | O94898 | |
| SSQFKRSLELLMRTL | 611 | Q13402 |